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Chapter 1 
General Introduction 
I 
A general introduction to the subject of this thesis and the aim of this work is 
given in this chapter. The basis of drug photochemistry is reviewed and scope and 
new perspectives for this research, in terms of photochemistry of photosensitizing 
drugs, are also presented. 
Light  is a ubiquitous element of our environment with a tremendous impact on life. 
Sunlight is the ultimate source of energy and it plays a crucial role in sustaining the 
existence of living organisms on this earth and without light, life as we know it, 
would not exist. Plants harvest solar energy by photosynthesis, and provide energy to 
other organisms through the food chain. Humans and animals depend on light through 
vision and other photoresponses. UVR in sunlight is critical for vitamin D synthesis in 
the skin. However, it produces a variety of pathological effects, including sunburn, 
pigmentary change. immunologic alterations, and neoplasia. A constellation of 
structural alterations of the epidermis, the dermal-epidermal junction, and the dermis 
is uniquely characteristic of photodamage. Thus, both, the beneficial effects and the 
harmful effects of light are well recognized and there is growing awareness of the 
influence of light (both beneficial and harmful) on living organisms I.2 
O_rt'gen is also a ubiquitous element of our environment with a tremendous impact on 
animal and plant life. Molecular oxygen is a unique and fascinating molecule that is 
integral to many processes that occur on earth ;. It plays a key role in the maintenance 
of life, and in mechanisms by which life is extinguished and materials destroyed. 
Oxygen is not only fundamentally essential for energy metabolism and respiration, 
but it has been implicated in many diseases and degenerative conditions. The parallel 
role of oxygen as a destructive (toxic) agent for living tissues has been discovered 
much more recently. Since oxygen is ubiquitous and efficiently quenches 
3 
electronically excited states, '02 is likely to be formed following irradiation in 
countless situations and involved in various chemical and biological processes as well 
as in several disease processes. Reactive intermediates include singlet oxygen (1 02, a 
metastable excited state of molecular oxygen), superoxide ion, and other reactive 
oxygen species: 'Oz, O[, OH , HOz , ROz' ,despite its acknowledged significance, 
the study of oxygen and oxygen-dependent processes continues to present challenging 
problems 5. 
Xenobiotics are any chemical compounds that are found in a living organism, but 
which are foreign to that organism, in the sense that it does not normally produce the 
compound or consume it as part of its diet ". For example, in humans, most drugs are 
considered xenobiotics, since we don't produce them naturally, or consume them in 
our normal diets. Xenobiotics are extensively used in, for example, drugs, cosmetics, 
food and agricultural chemicals. The human body is exposed to wide array of 
xenobiotics in one's lifetime, from food components to envirotunental toxins to 
pharmaceuticals and pesticides 7. 
A combination of light and xenobiotics, in the presence or absence of oxygen, often 
produces an undesirably menacing situation in biological systems. Although 
xenobiotics are very useful and almost indispensable, many of them are 
photosensitizer. They can produce adverse biological (phototoxic) effects due to 
ubiquitous light and oxygen- and the resulting photochemistry 8. 
In this context, a photosensitizing agent can be defined as a compound whose 
chemical configuration endows it with the ability to absorb UV radiation or visible 
radiation° and to undergo a light-dependent photochemical reaction resulting in the 
generation of highly reactive, relatively metastable (long-lived) intermediate states 
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(e.g., triplet state, free radical state, and ions) that cause chemical and functional 
modification in other molecules of biological systems 'o 
Ultraviolet light, which is divided into three parts with arbitrary limits, ie, UV-A 
(320-400 nm), UV-B (290-320 nm) and UV-C (200-290 nm), is characterized by its 
short wavelength (high energy). UV-A and UV-B are able to pass through the 
different layers of the atmosphere and reach earth, but UV-C is blocked by the ozone 
layer of the atmosphere. The wavelengths of the UV-B (290-320 nm) and UV-A 
(320-400 nm) region of the spectrum, imperceptible to the human eye, are an 
inherent part of our everyday life IL 12 . UV-B frequencies are absorbed in the first 
layers of the skin, composed by the. dead cells of the stratum comeum; however, 
wavelengths in the UV-A region are able to reach the blood irrigation system. 
Xenobiotie species are transported through the blood system, will eventually reach 
superficial areas in the body. where they will readily absorb the incident radiation 73. 
An ample range of photophysical and photochemical reactions may possibly occur at 
this instance, reactions for which the organism has not evolved to protect itself. These 
xenobiotic-incident sunlight interactions can be very detrimental for living tissues 
since they can produce a variety of biological effects: phototoxicity, immunological 
reactions, and cancer etc 14. 
Photosensitized reactions in skin can he beneficial, such as in photodynamic therapy 
of cancer (PDT) and use of psoralens and UVA radiation in PUVA therapy "of 
psoriasis. 
Photosensitization is among the new trends in photobiology and the photosensitizing 
effects of xenobiotics are of increasing concern in, since modern life style often 
5 
associates sunlight exposure with presence of chemical substances (xenobiotics) in the 
biological systems 16 . 
All the photobiological responses to light are the consequences of photochemical 
changes produced in biological systems. Photobiologists working with ultraviolet 
radiation are concerned with identifying the photochemical changes that are produced 
in living tissue by the absorption of ultraviolet light and determining the biochemical 
and physiological responses of cells to this damage ''. In this context it is important to 
stimulate more chemists to work on the molecular basic of photobiological problem. 
A chemist, in addition to identifying photoproducts, can contribute to the 
understanding of photobiological phenomenon by studying the details of 
photochemical steps. Once the photochemical mechanism is known it is usually 
possible to learn how to modify the photochemistry which is quite useful for relating 
molecular events to photobiological phenomenons ' 
The area of photobiology that is presently best suited for significant input from 
photochemist is that of photo sensitization of biological system. The number and 
variety of photosensitizing compounds are large. Furthermore, for most phototoxic 
xenobiotics a correlation between structure and photoreactivity I ') is not easily found. 
It is obvious that, in general, there must be a relationship between photochemical 
behavior and phototoxicity. 
It is therefore highhv desirable to put on record the photoreactivittiv of all common 
chemicals that may be exposed to sunlight. In the present study emphasis has been 
placed on the photochemistry of photosensitising drugs. 
Drugs have become very essential xenobiotics for human life these days. Several 
families of drugs have attained therapeutic importance because they exhibit anti- 
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inflammatory, analgesic, antipyretic, diuretic, and also antibacterial properties. A drug 
substance or drug product can be exposed to natural or artificial light during 
production, storage, administration and use. As many drug substances and some 
formulation excipients (e.g., pharmacologically inactive ingredients in pharmaceutical 
preparations) absorb optical radiation in the UV (290-400 rim) or visible (400-800 
rim) part of the spectrum, they have the potential of being photoreactive in vitro 
and/or in vivo 20. The photoreactivity of a drug substance or drug product describes 
how efficiently and by which reaction pathway the compound or formulation 
responds to optical radiation. Irradiation has two main effects on drugs: 
The first is the influence of light exposure on the stability of the drug substances and 
drug formulations leading to the drug photodegradation 2 '. The second aspect of 
drug—light interactions may result in the formation of free radicals and/or reactive 
oxygen species (e.g., singlet oxygen, superoxide, hydroxyl radical, peroxides, peroxy 
radicals, etc.) and also reaction with biological molecules, resulting in drug-induced 
photosensitivity and the biological effects 22. The photoinduced reactions might or 
might not be identical in vitro and in vivo, depending on the environment and 
chemistry of the absorbing species. Basic knowledge on the reaction mechanisms for 
the individual drug substances and products is important to ensure a safe handling, 
packaging and labeling of the products, to reduce the potential for adverse effects, and 
to optimize drug therapy by, e.g., developing new drug delivery systems, 
formulations, or therapeutic regimes 23  
Drugs belonging to various pharmaceutical classes are photosensitiztng: antibiotics, 
non-steroidal anti-inflammatory drugs, diuretics, antimitotic drugs, psychiatric drugs, 
amiodarone, calcium channel blockers and fibric acid derivatives. Many sensitizing 
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drugs are known to exert photoinduced adverse biological effects, such as 
phototoxicity, photoallergy, photomutagenesis and photocarcinogenesis'4. fn general, 
the generation of an adverse photosensitivity response can be postulated to involve 
one or more of the pathways shown in Fig. I.1. 
The topic of drug photochemistry has always received a considerable amount of 
attention but recently the interest has markedly increased due to the awareness among 
the scientific community of an increase in the UV portion of the sun spectrum 
reaching the earth and an increase in exposure to artificial light sources such as 
daylight lamps and solaria; a change in human leisure habits (more time spent 
outdoors); and a widespread use of drugs 25-29  As the mechanisms of both drug 
photodegradation and photosensitization are inter-related, recently, this attention has 
re-oriented to include the problem of biological photosensitization by drugs. The 
number of drugs that are found to be photochemically unstable or able to induce 
phototoxic side-effects is steadily increasing, hence the molecular mechanisms of 
adverse photosensivity reactions to drugs is of great concern. Because a detailed 
understanding of the molecular mechanism of photosensitization by drug is 
essential to anticipate and prevent the appearance of phototoxic or photoallergic 
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Fig.1.1 General scheme of possible reaction processes by which a photosensitizing 
drug may give rise to adverse photnhiological effects (phototoxicity). 
side- effect, this field requires a systematic and careful photochemical study of the 
drug of interest. This includes isolation of photoproducts, identification of intervening 
excited states and reactive intermediates, photoreaction with biological targets, where 
a photochernist can play a significant role. The interest of photochemists in the 
properties of the electronically excited states of compounds of pharmaceutical use has 
been rapidly increasing during the last decade. The majority of the work done in the 
last few years concerning the mechanisms of both drug photodegradation and 
photosensitization has appeared in recent reviews J0-35 
Photochemistry of drugs 
The photochemistry of drugs does not differ, in general terms, from that of the other 
molecules, and can therefore be rationalized (and can be roughly predicted) according 
to the same generalizations that are useful in organic photochemistry. 
Photochemical damage to a substance is initiated by the compound's or a 
photosensitizer's absorption of energy. Many photochemical reactions are complex 
and may involve a series of competing reaction pathways in which oxygen may play a 
significant role. In fact, the great majority of photoreactions in biological systems 
involves the consumption of molecular oxygen and is photosensitized oxidation z`' 
processes. 
Consider first the photophysical processes, which can be best described by an energy-
level diagram (Figure 1.2) and equation 1.1 to equation to 1.7. 
Any L; VR- or visible light-induced process begins with the excitation of drug 
molecules or sensitizers, from their ground state (Do) to reactive excited states, by 
absorption of photons of certain wavelengths as shown in equation 1.1. upon 
absorption of radiation, the drug molecule, Do,. in the ground state in which the 
valence electrons are paired or antiparallel (a spin singlet state) is raised to a higher 
energy level, as a valence electron moves to the first available outer shell 
corresponding to the first excited singlet state, 'D (the electron spins remain 
antiparallel). When the absorption spectrum shows more than one absorption band, 
this indicates a corresponding number of excited states that can he reached by 
irradiation with the appropriate excitation wavelength. The molecule cannot persist in 
an excited state indefinitely because it represents a less stable situation with respect to 
the ground state. A variety of competing physical processes involves energy 
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dissipation and result in deactivation of the excited states. The energy dissipation may 
be via internal conversion (IC) (Equation 1.2), which is a nonradiative transition 
between states of like multiplicity, or via photon emission (fluorescence) resulting in 
return to Do (Equation 1.3). 
Absorption : Do + 	hv — 1 D (1.1) 
Internal converrsion : 1 D Do (1.2) 
Fluorescence : 	D i Do + hv (1.3) 
Photoionization : 1 D D+ + a (1.4) 
Intersystem crossing: 1D —— 3D (1.5) 
Intersystem crossing: 3D Do (1.6) 
Phosphorescence : 	3D - 	Do + hv" (1.7) 
thermal activation 
IC 
	
VR ISC 	 5________ 
ISC" 
	 VR 
Absorption / 
Fluoresc 
VR 
Phosphorescence 
Do 	 U 
	 3D 
Fig-1.2 Energy levels of molecules showing transitions involving fluorescence, 
phosphorescence, internal conversion, and intersystem crossing. 
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Even if excitation occurs to an excited state higher than the tirst, IC will always bring 
the molecule to the 'D level (within a picosecond) before fluorescence occurs. Thus, 
the fluorescence emission wavelength is the same, irrespective of the irradiating 
wavelength. Any excess energy within a particular electronic state is dissipated as 
heat by collision with neighboring molecules-referred to as vibrational relaxation 
(V R). 
Because the lifetime of the excited singlet state of a molecule is generally of the order 
of nanoseconds (but up to microseconds for rigid molecular structures), the possibility 
of interaction with neighbouring molecules leading to chemical change is limited at 
this stage. However, in the excited singlet state, the ionization potential of the 
molecule is reduced; the excited electron is more easily removed than it is from the 
ground state molecule, but requires an appropriate acceptor to be present. This process 
of photoionization (Equation 1.4) is also more likely to occur if higher energy 1?VR is 
used (i.e., wavelengths less than 300 urn) and if the molecule is in the anionic state. 
Alternatively, intersystem crossing (ISC) may occur from the excited singlet state to a 
metastable excited triplet state 'D (electron spins parallel) (Equation 1.5). Despite the 
low probability in general for transfer between states of differing multiplicity, ISC 
occurs with relatively high efficiency for most photochemically active molecules. 
Because of its longer lifetime (microseconds to seconds, or even longer), the excited 
triplet state may diffuse a significant distance in fluid media and therefore has a much 
higher probability of interaction with other molecules. If no interaction occurs, it 
decays back to the ground state by another ISC event {Equation 1.63, or by 
phosphorescence emission (Equation 1.7). 
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The nature of the excited state decay processes is studied by the technique of laser 
flash photolysis, a description of which has been given by Bensasson et al. ' l Briefly, 
flash photolysis involves irradiating a sample with a short (nanosecond) intense pulse 
from a laser, then observing by rapid response spectrophotometry the spectral changes 
that occur on the time scale nanoseconds to milliseconds. Several standard tests have 
been established to aid in the identification of the transient species. Solvated electrons 
generated by photoionization in a nitrogen-gassed solution have a characteristic broad 
structure less absorption peak at about 700 nm, depending on the solvent (720 nm in 
aqueous solution). Oxygen quenches this absorption and also quenches the triplet 
state, while nitrous oxide gassing can be used to quench the solvated electron only, 
thereby gaining an indication of any transient absorption that arises from the triplet 
state. 
One difficulty with flash photolysis experiments at present lies with the laser exciting 
source. To achieve the required pulse intensity, the source usually employed is an Nd-
YAG laser emitting at 1064 nm, with frequency doubling to produce 532 nm, tripling 
to 355 nm, and quadrupling to 266 nm. As far as the majority of drugs are concerned, 
this provides excitation at very specific wavelengths of 266 or 355 nm, leaving an 
unfortunate gap in the 280- to 340-nm region. Thus, for many drug molecules whose 
absorption does not extend to 355 nm, one is forced to use the high-energy 266-nm 
excitation, which may produce upper excited states and lead to events such as 
photoionization. In the context of photodegradation initiated by UVR greater than 300 
nm, some of these events may not be relevant. The efficiency, or quantum yield, of 
each of the processes described by equation 1.2 to equation 1.7 is defined as the 
13 
fraction of the molecules excited by absorption (Equation 1.1), which then undergo 
that particular mechanism of deactivation. 
Although the quantum yield of fluorescence is readily determined by reference to 
quinine fluorescence as described by Calvert and Pitts is, those of the other processes 
can only be obtained by difference. Phosphorescence is usually too weak to be 
observed in solution at room temperature, but can he measured if the drug is held in a 
glassy matrix at low temperature. The usual procedure is to dissolve the drug in 
ethanol and immerse in liquid nitrogen. The phosphorescence accessory of the 
fluorimeter incorporates a mechanical chopper enabling the phosphorescence to be 
observed free of interference from any fluorescence. Because of the difference in 
temperature and matrix, it is not possible to compare the phosphorescence yield with 
that of fluorescence. Nevertheless, phosphorescence is worth measuring because it is 
an important indicator of the capacity of a molecule to populate its triplet state. 
The excited molecule has a different electronic character compared to the ground state 
and is often able to form a complex (called an exciplex) with another species 
(designated as Q), i.e., the complex is D*Q. The symbol Q is used because, in effect, 
the interacting molecule is a quencher of the native fluorescence of D. Sometimes, at 
a high concentration of the absorbing molecule, this occurs with the ground state (in 
which case the D*D species formed is called an excimer). The formation of the 
exeiplex or excimer is observed as a shift in the fluorescence emission to longer 
wavelength-the difference in energy between exciplex and normal fluorescence 
reflecting the stability of the exeiplex. More details of this type of interaction can be 
found in Gilbert and Baggott 39. 
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The substances for which this phenomenon has been observed are invariably 
polycyclic aromatic hydrocarbon structures. No exciplex formation has been reported 
in the literature to involve drug molecules, but this remains a possibility in 
concentrated solution or perhaps in solid-state mixtures. The consequences of 
exciplex formation are a radiative or nonradiative return to the ground state without 
chemical change, or electron transfer leading to chemical reaction of the drug, the 
quencher, or both. Many photoaddition processes are postulated to proceed via 
exciplex formation with the quencher molecule becoming chemically bound. 
The electronically excited state of a molecule will act as a more powerful electron 
donor or acceptor than the ground state. The reactions that can occur are, respectively, 
oxidative or reductive quenching: 
Oxidative quenching: D`♦ Q 	- DQ 	D'* + l2 _ 	(1.8) 
Reductive quenching D`Q 	- D + Q + 	 (1.9) 
The exact nature of the reaction (oxidative vs reductive) will depend on the redox 
properties of D* and Q. The electron transfer process is a special case of exciplex 
formation favored in the strongly polar solvents, such as water. The involvement of an 
exciplex in a photochemical reaction is generally established by studying the effects 
of known exciplex quenchers such as amines on the exciplex fluorescence and the 
product formation. The heavy atom effect, due to the presence of substituents such as 
bromine or iodine intra- or intermolecularly, causes an exciplex to move to the triplet 
state preferentially, with a quenching of fluorescence. 
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Mechanism of photosensitization induced by drugs 
Photosensitivity is a broad term used to describe unwanted phototoxic reactions of 
pharmaceutics to nonionizing radiation. Photoloxic response to systemically or 
topically administered drugs requires exposure to the appropriate wavelength of light, 
especially UV-A and UV-B radiation, and the presence of drug in the skin. In 
phototoxic reactions, the drug absorbs energy from UVA/UVB light and releases it 
into the skin. The optional initial processes are the same both in vitro and in vivo but 
the photoinduced reactions might or might not be identical in vitro and in vivo, 
depending on the environment and chemistry of the absorbing species. 
The ability of the photosensitizing drug to induce phototoxic response is believed to 
occur either by formation of photoadducts with biomolecules or through generation of 
reactive oxygen species (ROS), including singlet oxygen and superoxide, which 
selectively modify various oxidative reaction mechanisms. Unsaturated membrane 
lipids in mammalian cells, including glycolipids, phospholipids, and cholesterol, are 
well-known targets of damaging and potentially lethal peroxidative modification. In 
addition to lipid peroxidation, it is well established that ROS react with nuclear DNA, 
resulting in the photodynamic breaking of the DNA strand. The DNA breakage was 
found to be facilitated by a non covalent drug-DNA interaction, induced by both 
electron and energy transfer to DNA, as recently suggested for some NSAIDs '. In 
this context, the primary event in any photosensitization process is the absorption of a 
photon, and the following free radical and singlet oxygen generation by photo excited 
drug molecules may seem to be the principal intermediate species in the phototoxic 
response. Thus, it has been rationalized that four pathways are usually considered 
available for the excited photosensitizing drug to exert phototoxic effects on some 
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target in the biological substrate. These are: singlet oxygen tbrmation, radical 
formation, covalent photobinding and production of photoproducts in decomposition 
reaction. The molecular mechanism of photosensitization induced by drugs can 
proceed through several pathways and may involve the presence or absence of 
oxygen, leading to a very complicated picture. Associated with its own chromophoric 
structural features, it is the individuality of the drug to follow the course of 
photodegradation and photosensitization. 
The first event in photosensitization by drugs (D) is the absorption (A) of a photon, 
which promotes the drug to its excited singlet state ('D*).  This is a high- energy 
species, which can undergo deactivation via different pathways. 
(a) Fluorescence emission (FL). 
(b) Internal conversion (ISc) to the ground state. 
(c) Intersystem crossing (ISc) to an excited triplet state (3D*). 
(d) Ionization to give a radical cation plus an ejected electron (D-' '+ e- ). 
(e) Unimolecular reactions such as fragmentation to free radical (R) or 
transformation in to photoproducts (P). 
(t) Inter molecular processes, such as energy transfer, electron transfer or chemical 
reactions (for instance cycloaddition ). The partner reactants are usually a 
biomolecules (B) or oxygen present in the medium. 
After intersystem crossing (path (c)), the resulting excited triplet ('D*) 
can undergo similar deactivation processes. 
(g) Phosphorescence emission (PH). 
(h) ISC to ground state. 
(i) Ionization (to give D' + e-). This is less favoured from the thermodynamic point 
17 
of view than ionization from D*,  because of lower energy of 'D*. 
0) Unimolecular photochemical reactions leading to free radical (R') or stable 
photoproducts (P). 
(k) Intermolecular processes (energy transfer, electron transfer or chemical 
reaction).Owing to the higher half -life of triplet states, these processes are 
more likely to occur than those taking place from I D*. 
'Sc 
FL 
ISC 
A 
PH 
G 
Fig-I.3- Diagram showing generation of the excited states involved in 
photosensitization by drugs 
Processes (d), (e), (i) and (k) are more frequently involved in mechanism of 
photosensitization by drugs (fig. 1.3). The so- called type-I and II mechanisms are 
oxygen dependent. The former is based on initiation of chain reaction by free 
radicals, whereas the latter is associated with singlet oxygen. By contrast, type III 
photosensitization processes do not involve oxygen. Instead, stable photoproducts of 
the drug or covalent photoproduct of the drug to biomolecules are in origin of the 
observed photobiological effects. 
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A collection of examples from literature is presented in the following pages 
to illustrate the in vitro photoreactions of various classes of phobia bile 
drugs and rheirphotodegradation mechanism. 
Anti-histaminic and immunosuppressant drugs: 
Among drugs with anti-histaminic action, thiazinc derivative promethazine (1) upon 
irradiation, N-dealkylated to phenothiazine (2) which in turn oxidized to the sulfone 
(3) and to the 3H-phenothiazine-3-one 41 (4) (Scheme 1.1). Another drug mequitazine 
(5) a phenothiazine derivative upon irradiation gave the corresponding sulfoxide 42 (6) 
(Scheme 1.2). Antihistaminic drug terefenadine (7) undergoes oxidation (main 
process) and dehydration at the benzylic position to give products (8) and (9) 
respectively, upon irradiation in aqueous solution (Scheme 1.3). 
19 
S , 
N- 
Me 
NMe2 
(1) 
0 
1 
- by  
h 	
- 
	SCI.  
H 
(2) 
	
(3) 	(4) 
Scheme 1.1 
by i" N 
L 	xsx 
0 
(6) 
Scheme 1.2 
HOPh2C-  : N (CH,hCH 
OH 
(7) 
by 
HOPh,C 	N (0H2)1C 	- tBu + HOPh2C 
0 
(6) 
tBu 
N-(CH2)1 C C 'C( )tBu 
(9) 
Scheme 1.3 
20 
Antihistaminic drug fexofenadine hydrochloride °' (10) undergoes decarboxylation 
and rearrangement of aromatic rings followed by oxidation reaction to give products 
(11) and (12) respectively, upon irradiation in methanol solution (Scheme 1.4). 
H ~~ . CH1 
HO 	N 
	
~— CH, 
OH 	HO ' 0 
(10) 
C 
/ H 
HD 	N V~` 	;r 	CHI 
r , 	OH 	H 
(11) 
( 
	0 
 !1 A. H : _=. CHI 
_E 	N V \-,. 	it 	OH, 
OH ~Ho `O 
(12) 
Scheme 1.4 
The immunosuppressant drug azathioprenc (13) undergoes fi-agmentation of the C-S 
bond to give 6-mercaptopurine (14} and 1-methyl-4-nitro-5-hydroxyimidazole (15) as 
well as cyclization reaction suggested to give (16) 45(Scheme 1.5). 
NO2 N--/ 
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H H N N, 
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Scheme 1.5 
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:%On steroidal an ti-in lamtitatory drugs: 
A variety of 2-aryl propionic acid derivatives 46.47 are used as anti-inflammatory 
drugs. Most of these are photoreactive and have some phototoxic action. As a 
consequence, their photochemistry has been intensively investigated. The main 
process in aqueous solution is decarboxylation to yield a benzyl radical, a general 
reaction with a-arylcarboxylic acids ;x. Under aerobic conditions, benzyl radical 
undergoes dimerization or reduction  (and in an organic solvent abstracts hydrogen). 
In presence of oxygen, addition to give hydroperoxy radical and the corresponding 
alcohol and ketone (Scheme 1.6). 
ArCHRCOOH 	 ArCHR 	ArCHR12. ArCH2R etc 
ArCHROO 	ArCOR, etc 
Scheme 1.6 
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The results from the irradiation of naproxen (17) in water are shown in Scheme 1.7, 
and a related chemical course is followed with several drugs pertaining to this group, 
such as ibuprofen 0, butibufen 51, flurbiprofen 50, ketoprofen s" s3, suprofen,sa 
benoxaprofen,51. ss tiaprofenic acid 56 and ketorolac tromethamine 57 (21) (Scheme 
PhCO 	 by 
N 
--COO NHC(CH2OH)3 EtOH or H2O 
PhCO— I"'  N X 
X = CH2, CHOH, CHO2H, CO 
(21) 
	
(22) 
Scheme 1.8 
For Indomethacin (23) in methanol decarboxylation is the main process,5A' 	when 
mercury lamps are used, while day light irradiation leads to products conserving the 
carboxyl group which have been rationalized as arising via the acyl radical (Scheme 
1.9).x'" The anti-inflammatory agent diclofenac (24) undergoes sequential loss of the 
two chlorine atoms and ring closure i`1 (Scheme 1.10). Meclofenamic acid `'2 (27), 
similarly undergoes dechlorination and cyclization to give carbazoles (28) and (29) 
(Scheme 1.11). 
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Photo reactivity has been reported also for some anti-inflammatory and analgesic 
drubs `';-` 5 different from aryl acetic acid. 
Glit co co rticostero ides: 
The photoreactivity of glucocorticosteroides have been explored both in solution as 
well as in solid state and it is well known that they have to be protected from light. 
Hydrocortisone (30), cortisone (31) and their acetates 66 (32, 33) undergo 
photooxidation in the solid state. The main process involves loss of the side chain at 
C-17 to give androstendione and trione derivatives respectively (scheme 1.12). 
Molecular packing has an important role in determining the photostability in the solid. 
As an example irradiation of crystalline hydrocortisone tort- butylacetate leads to the 
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photooxidation of two over five of the polymorphs investigated. This fact has been 
correlated with the possibility of oxygen to penetrate in the crystal in such structure 
COCH2R 
I OH X 	 hv,N2 
solid 
0 
X ~ Ji 
0 
(30) _ OH R= H 	(32) 
(31) H R=OAc (33) 
.'l 
0 
R= H 
X=CO R= OAc 
Scheme 1.12 
Cross conjugated glucocorticosteroides such as prednisolone (34), prednisone (35), 
betamethasone (36), triamacinolone (37) and others are quite photoreactive, as one 
may expect since the efficient photorearrangernent of cyclohexadienones to bicycle 
[3.1.0] hcxanones is well known 61. This rearrangement has been observed for 
dexamethasone, prednisolone, betamethasone and some of their acetates 69.70 
(Scheme 1.13). The primary photoproducts may undergo further transformation with 
cleavage of the three membered rings resulting in rearomatization or cleavage of ring 
A or in expansion of ring B. 
Clobetasol propionate ?1, desonide72, flumethasone " and fluticasone furoate74 the 
glucocorticoid derivative shows similar type of reaction pattern. 
Hydrocortisone acetate (38) is a glucocorticoid used in therapy for the treatment of 
different rheumatoid and allergic pathologies and dermatitis, both by systemic and 
topical way. On irradiation of (38) with UVB light in methanol solution undergoes 
photodegradation, yielding five photoproducts (39, 40, 41, 42, and 43). Photoproduct 
(40) lacks the ketolic chain as a consequence of the Norrish type I mechanism and C- 
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17 is oxidized to a ketone. (40) undergoes further horcolytic scission to an 
intermediate which photoisomerizes to give (41), binds to the solvent to give (43) , or 
rearranges to give (42) alternatively, (38) undergoes a Yang-type reaction which 
yields a cyclobutane derivative 7 ' (39) (Scheme 1.14). 
COCH2OR COCH2OR 
OH %~ J OH 
R" ; by = 	 I 0 
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O' 
X R R• R•• 
(34) CO H. Ac H H 
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(36) C OH H, Ac F Me 
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(37) C_OH H F Me 
H 
Scheme 1.13 
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Drum actin_f on central nervous system: 
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5, 5-alkyl derivatives of barbituric acid (44) are used as hypnotic and tranquillizers. 
These compounds undergoes two types of photochemical reactions (Scheme 1.15). In 
first type of reactions cleavage of the C(4)-C(5) bonds takes place which leads to the 
formation of an intermediate isocyanate (path a), which in turn adds nucleophilic 
solvents to give an amide (45) in water and urethane (46) in ethanol. The positive 
evidence for the formation of isocyanate has been obtained by irradiation in the solid 
state ``'. H. Barton et al. "studied similar type of reaction pattern in case of barbital 
(47, R, R'=Et, R"=H) and its methyl derivative (48, R, R'=Et, R — =Me). The second 
one involves cleavage of second C-C bond with the elimination of CO (path b). H. 
Barton et al.'s' ~`' obtained similar reaction pattern with mephobarbital (49, R=Et, 
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R'=Me, R"=H) which leads to hydantoin (50) as product. Different process occurs for 
the acidic forms of cyclobarbital (51), which is photooxidized to ketone (52) rather 
than cleaved (Scheme 1.16). 
For the tranquillizer proxibarbital %° (53) it was suggested that a nucleophilic group in 
the side chain intervene in the process via intermolecular addition and gives the 
tetrahydroteran (54) (Schemel_17). Monulky1barbiturate 	(55) undergo 
hydroxylation at position 5. 2-thin analogue of phenobarbital (56) gives (57) by 
selective reduction of the thiocarbonyl function by irradiation in alcohols (Scheme 
1,18) 82 
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.Aubert Maquille et al A ~ studied the photodegradation of the antipsychotic drug 
flupentixol (58), at 254 am in aqueous solutions. A total of nine photoproducts were 
detected after irradiation of the drug. The main photoproduct is generated following 
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the addition of a hydroxyl group on the double bond adjacent to the thioxanthene ring. 
Secondary photoproducts were also observed (Scheme 1 .19). 
Photostability of amisulpride fl4 (68) under UVA irradiation in methanol solution was 
investigated. Four photodegradation products were observed as depicted in scheme 
1.20. 
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An rrh vperten si ve.s: 
4-nitrophenyldihydropyridines are widely used as vasodilators and due to presence of 
hydrogen abstracting nitro group and easily abstracting penzylic hydrogen these drugs 
considered to be quite photorcactive. Reduction of nitro to nitroso group of 
heterocyclic ring and re oxidation of nitroso group in presence of oxygen are mainly 
observed reaction paths (Scheme 121). Nifedipine &D8? (73) the 4- 
nitrophenyldihydropyridine derivative shows similar type of reaction pattern. other 
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nitrophenyidihydropyridine derivative such as nicardipine (74) g", fumidipine (75) B9 
and nimodipine (76) 90 also photo react in the similar manner. 
NO NOS  Cam' 
R'OOC 	COOR by 	R'OOC 	COOR _i_ R'OOC O  ,COOR 
solution 
solid 	N Me N 	or 	M Me 	 e N Me 	 Me N Me 
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(74) R= Me, R'=[(N-methyl-N-henzyl)-2-aminoethyll 
(75) R,R =Et, 2-tetrahydrofurylmethyl 
(76) R, R' =so-propyl.2-methoxyethyltetrahydrofurylmethyl 
Scheme 1.21 
Bamidipin 91 (77) a new 1, 4-dihydropyri dine antihypertensive drug, by exposing the 
drug to natural and stressing light irradiation. Different photoproducts were obtained 
(Scheme 1.22). In this case, barnidipine was subjected to the aromatization of the 1,4 
dihydropyridine moieties, reduction to the nitroso-derivatives and N-debcnzylation on 
the side chain as major photodegradation reactions. 
Diltiazem (83) is stable in solid state ' but on irradiation of aqueous solution at 
different p1l it gets deacetilated 93 (Scheme 1.23). On irradiation of aqueous solution 
of erogotainine under nitrogen atmosphere obtained product due to hydration of 
double bond at 9, 10 position. Reserpine (86) photoreact both in aqueous solution and 
in chloroform and the process occurring are epimerization at C-3 and stepwise 
dehydration of the tetrahydro oarboline skeleton''' 9' (Scheme 1.24). 
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Ben<,odiazepines: 
They are generally photolabile, but the path followed in the degradation depends on 
the structure of each derivative and on the reaction condition. Moore et al.`" obtained 
benzophenone (88) as main product by the irradiation of diazepam (87) at 300 rim in 
McOH-H20 through the cleavage of heterocyclic ring, and dihydroquinazoline (89) 
by irradiation at 254 nm in methanol. This compound then slowly isomerizes to (90) 
as well as to (91) and (92) through dechlorination and oxidation (Scheme 1.25). 
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Anderson et al 91' 9' studied intravenous anesthetic midazolam (93) which undergoes 
ring restriction to quinazoline (94) as well as oxidation to 5-fluorophenyl moiety to 
give (95) and (96) (Scheme 1.26). Roth et al.9, obtained different reaction pattern in 
case of nitrazepam (97) because of the insertion of nitro substituent, this abstracts 
hydrogen and reduced to azioxy, azo and amino function by irradiation in organic 
solvents under nitrogen. The hypnotic flunitrazepam (98) undergoes a multi step 
reduction finally leading to the 7-amino derivative under anaerobic conditions1°"''01. 
While it is N-demethylated to give (99) in presence of oxygen (Scheme 1.27). 
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Chlorodiazepoxide 102 '103 (100) in which photochemically active moiety N-oxide is 
present rearranges to oxaziridine (101) and Curther reacts to give compound (102) and 
(103) through ring contraction and ring expansion respectively. J. Reisch 1° solid 
state photochemistry of chlordizepoxide obtained quinazoline (102) ring opened 
product (105) and (106) was also obtained (Scheme 28). P. J. G. Cornelissen 10S also 
studied some compounds in presence of reducing agent such as giutathione where the 
main observed process is N-deoxygenation, to (104). 
Photochemical degradations of a)prazolam 10M1 (107), a benzodiazcpine derivative, 
extensively used for the control of panic attacks and in the management of anxiety 
disorders have been studied. The photo product obtained as triazolaminoquinoleine 
(lOS), 5 -chloro-[5'-methyl-41I-L 2. 4-tria2ol-4 yl] benzophenone (109) and 1- 
methyl-6-phenyl- 4H-s-triazo- [4,3-a] [1,4] bcnzQdiazepinone(lL0)(Sehcmc 1.29), 
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Antihacterials: 
Golpashin et al.1°` studied several N-substituted sulfanilamide derivative and reported 
that yields of products changes with the structure. The main process takes place is the 
cleavage of C-S and S-N bonds with the elimination of SO2 and formation of aniline 
(111) and appropriate amine (112) (Scheme 1.30). Chiang et al. 1" observed that 
methylation of amino group take place on irradiation of sulfadimetoxine in methanol. 
Irradiation of sulfacetamide (113) in water yielded deacetylated product sulfanilamide 
(114), which on further oxidation of amino group to give azo (115) and nitro (116) 
derivative,10  whereas in ethanol "0 oxidation of solvent to acetaldehyde takes place 
with the formation of 2-methylquinoline-6-sulfonamide (117) (Scheme 1.31). 
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Linezolid  " (118) an antibacterial oxazolidinone derivative is known to be liable to 
degradation under photochemical conditions result in the formation of photoproduct 
as (119. 120). A likely mechanism involves the fragmentation of the C—F bond 
yielding the corresponding triplet phenyl cation. This intermediate either is reduced 
or, under appropriate conditions, intersystem crosses to the singlet state that adds the 
solvent. These data demonstrate a sizeable photodecomposition of this drug (Scheme 
1.32). 
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Darvis et al. 11- and Moore et al.' 1- carried out irradiation of aqueous solution of 
tetracycline (121) under aerobic condition which causes homolytic deamination with 
the addition of oxygen, resulted in the formation of quinine (122) (Scheme 1.33). 
Chlorotetracycline on irradiation in aqueous buffer solution at pH 7.4 undergo 
homolytic dechloroniation 114. 
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Scheme 1.33 
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Aqueous solution of chloramphenicol 115-11 (123) gives glycolic aldehyde (121), 
dichloroacetamide (125) and 4-nitrobenzaldehyde (126) by the homolytic cleavage of 
C-C bond (Scheme 1.34). The resulting product 4-nitrobenzaldehyde undergoes 
secondary photoreaction and leads to amino and nitro benzoic acid as well as 
aminobenzaldehyde oxime. 
OHNHCOCHCl2 
02N 	CHCHCH20H hv - OZN 	CHO + CH OH + GHCl2CONH2 
(123) 	 (124) 	 (125) 	(126) 
Scheme 1.34 
The urinary anti-bacterial nitrofurantoin (127) is cleaved to nitrofuran carboxaldehyde 
upon UV irradiation. Furazolidone (128) is cleaved and hydrolyzed to nitrofuran 
carboxaldehyde (Scheme 1.35) lix 
0 
02N O CH N N X 
Y 
by — 02N O CHO NO2CHIOCH2CH NNHCONH2 
(127) X = NH, Y CO 
(1Y8) X=O, Y=CH2 
Scheme 1.35 
Among five membered heterocycles metronidazole (129) and related antibacterials 
show typical nitro group photoreactions Icy ,l . This initiated by typical nitro-nitrite 
rearrangement to give (130) followed by shift of NO group to vicinal position. 
Hydrolytic ring opening-ring closure from oxime leads to 1, 2, 4-oxadiol-3- 
carboxamide (131) which finally hydrolyzed to oxaldiamides (132) (Scheme-1.36). A 
different photochemistry of metronidazole 1 " was observed in presence of citrate. 
Irradiation of six membered heterocyclic drug isoniazid 123 (133) in ethanol caused 
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oxidation of ethanol to acetaldehyde which is trapped by substrate to yield hydrazone 
(134) which again reacts with a molecule of ethanol to give (135) (Scheme-1.37). 
Trimethoprim 124 (136) undergoes oxidation at benzylic position and hydrolysis of 
amino group in pyrimidine ring to yield (137) and (138) respectively as product 
(Scheme 1.38). 
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F(unrorruinalores: 
Quinolonc antibiotics bearing fluorine substituent are commonly called 
fluoroquinolones. The following processes have been indicated to justify the 
photoreactivity: i) singlet oxygen produced by the zwitterionic form resulting from 
dissociation of carboxylic acid and simultaneous protonation of the piperazinyl group. 
ii) the formation of reactive oxygen species including singlet oxygen, superoxide 
radical, hydroxyl radical and hydrogen peroxide, although; a mechanism based on 
these toxic agents does not appear to be correlated with the fluoroquinolone 
photoreactivity iii) the dehalogenation phoiochemically induced generating a highly 
reactive carberve C-S which reacts with some cell component iv) a combinated process 
wherein the hemolytic defluorination leading to the formation of aryl radical which 
triggers the attack to the cellular substrate whereas the oxygen rcacti.re species could 
operate either in a secondary or in a parallel process 125 . 
The photobehaviour of fluoroquinolone antibiotics has recently been the object of 
increasing interest due to the finding of their phototoxic and photocarcinogenic 
properties. The main result obtained for a series of structurally related, representative 
fluoroquinolone drugs is reviewed 126 . Both activation of oxygen and various 
degradation pathways have been identified and the effects of medium and structure 
have been rationalized. The results can help in the understanding of the 
photochemistry occurring in biological environments and in the assessing of the 
correlation between structural characteristics and biological photodatnage. 
The veterinary antimicrobial drug marbofloxacin (139) undergoes none of the general 
photoreactions of fluoroquinolones. Irradiation rather leads to hemolytic cleavage of 
the N—N bond and loss of a fragment to give a phenoxy radical. The final products 
42 
result from the dimerization, the reduction, or the disproportionation of the radical 127 
(Scheme 1.39). 
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Antiyrotozoal drums: 
Photochemistry of antiprotozoal drug quinine ' 2 occurring in citric acid solution has 
been extensively studied and this drug is well known to be photolabile. Photochemical 
oxidative degradation of alkyl amino chain is the main reaction paths observed in the 
majority of this class drug. 6-alkylamino derivative primaquine (142) 12t)J31), 4- 
alkylamino derivative arnodiaquine 131 hydroxychtoroquine (143) 132 and chloroquine 
(144) --1;1  undergo degradation of alkylamino side chain (Scheme 1.40, 1.41 and 
1.42). Tonnesen and Grislingaas 136 studied mefloquine (145), which undergo 
degradation of the alkyl amino side chain by irradiation in methanol and obtained 
(146) and (147) as main product (Scheme 1.43). 
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Antineophi.itic druj.'.s: 
Horton et al.' 3 studied irradiation of decarbazine (148) in solution which causes 
dimethylarnine elimination to yield diazo derivative (149) which further hydrolyzed to 
give hydroxyimidazole (150). This hydroxyimidazole in turn coupling with diazo 
derivative (149) to give azo derivative (151) or in other way cyclize to give 2- 
azahypoxanthinc (152) (Scheme 1.44). 
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Hedamycin and kidamycin 138 react photochemically in aerobic as well as in 
anaerobic conditions and undergo intermolecular hydrogen abstraction from 
tetrahydropyranyl ring in presence of oxygen to yield dihydropyranyl derivative, 
while reductive cleavage of epoxide ring of the chain at C-2 under nitrogen to form 
two products. 6-mercaptopurine (153) is oxidized when irradiated in oxygen 
equilibrated aqueous solution by near UV light giving sulfinate (154) as the primary 
product, which is finally oxidized to sulfonate 1 '`' (155) (Scheme 1.45). Several other 
anti-neoplastic drugs such as alkaloids vinblastinc sulphate, carmustine, taurornustine 
mitonaftide are found to be photochemically unstable. 
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Scheme 1.45 
The neuroleptic drug doxofyline 140 (156) is photolabile under UV-A and UV-B light 
in aerobic conditions. Irradiation of a methanol solution of this drug produces one 
photoproduct (157) (Scheme 1.46). The photoreactivity of phototoxic anti cancer drug 
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flutamide 141. .42 has also been studied in homogenous media, cyclodextrin cavity and 
liposomes. 
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CPT-11 (158) 1-03 a eamplothecin derivative used as an anticancer drug undergo 
photodegradation on irradiating with UV light afforded three photoproducts (Scheme 
1.47). 
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Gonadotrapie steroid and .synthetic estrogens: 
Synthetic estrogens are generally the stilbene derivatives. They undergo fast E-Z 
phototsomerization and trails fused dihydropheanthrene is formed by the conrotatory 
electrocyclic ring closure of the z-isomer which in turn get arornatized in presence of 
oxidants such as atmospheric oxygen. Clomiphene 144 (162) reacts similarly when 
irradiated in chloroform and each isomer cyclizes to corresponding phenanthrene (163 
and 164) (Scheme 1.48). Cyclization is observed also with temoxifen 	Dihydroxy 
substituted stilbenes such as stilboestrol (165) and dienoestrol (166) are likewise 
cyclized (Scheme 1.49 and 1.50) 
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The phenolic ring presents in the estrogens make them quite labile to photooxidation. 
Under the condition where singlet oxygen produced by photosensitization avoid direct 
photolysis of substrate. Sedee and co-worker 149 observed the same photosensitized 
reaction of ethinylestradiol (167) which involve singlet oxygen addition to electron 
rich phenolic ring to yield ketohydroperoxide (168). Similar reaction pattern was 
obtained in case of estrone '  (169) (Scheme 1.51). 
Me X 	 Me 
HOO 	
X 	 SOH 
(168) X = C 
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When photolysis is carried out in solid state different reaction paths are observed. 
Reisch et 	al. 1 s 	1 s` observed for testosterone 	(170), 17-methyltestosterone 	(171), 
levonorgestrel and ethisterone. Testosterone yielded androstenedionc (172) and 
androstanedione (173) while 17- methyltestosterone gives seco-derivative (174) 
(Scheme 1.52). Levonorgestrol and ethisterone are photodimerized in solid state under 
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nitrogen atmosphere 151. 154. Testosterone propionate (175) gives dimmer (176) when 
irradiated in solid state 155 (scheme 1.53). 
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Anti-diuretic drru is: 
The phototoxic diuretic drug furosemide (177) is photolabile under aerobic and 
anaerobic conditions. Irradiation of methanol solution of furosemide produces under 
oxygen atmosphere photoproducts such as (178), (179), (180) and (181) as well as 
singlet oxygen, while under argon atmosphere the photoproducts such as (178) and 
(179) were isolated (Scheme 1.54) 156 A peroxidic unstable product was also detected 
MO 
during the photolysis under oxygen atmosphere. Furthermore, a photocycloaddition of 
singlet oxygen to l'uran group of furosemide was also detected. 
COOH 
_NHC Hz 0 
COON HzNOtS - . 	179 
NHCHz,/OI (178) 
UI r 
HzN023 ~~ ,O CI R COON 
(177) 178 	 ~NHCHs- 	O I !\ N,i''C~~~ ♦ 
0 HiNOzS  HzNOzS~ 
CI CI 
(151) 
179 	R11 
180 	R=OH 
Scheme 1.54 
The photodegradation of amiloride t5' hydrochloride, an orally administered 
potassium-sparing diuretic agent in deaerated aqueous solution at 30°C in the pH 
range 4.5—I1.0 was studied. The initial photoreaction involves deehlorination of 
alniloride and the major product is N-amidino-3, 5-diamino-6-hydroxylpyrazine- 
carboxamide. The mechanism of photolysis is postulated to involve cation radical 
formation that facilitates the dechlorination step. 
The phototoxic diuretic drug chlorthalidone (182) is photolabile under aerobic 
conditions and UVB light. irradiation of phosphate buffered solution of this drug 
produces under oxygen atmosphere photoproducts (183), (184), (185) and singlet 
oxygen (Scheme 1.55). Its photolability under UVB irradiation was followed by 
progressive decrease in the main absorption bands at 220 and 280 nm `ss 
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The phototoxic antidiabetes drug glipizide {5`', a benzosulfonamide derivative, is 
photolabile under aerobic conditions and UVB light. Irradiation of phosphate buffered 
solution of this drug under oxygen atmosphere produces 4 photoproducts as well as 
singlet oxygen. Incubation of this preirradiated drug with the cell culture revealed no 
phototoxic effects. Its photochemistry involves cleavage of the sulforie-amine and the 
sulfonamine-R bonds. 
Hydrochlorothiazide 161) (186) is dimerized upon irradiation with a medium pressure 
Hg arc lamp through a glass filter in deaerated aqueous or alcohol solution to give 
(187) with quantum yield of 0.18 (Scheme 1.56). 
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Troglitazone "'1 is a new oral antidiabetic drug reported to be effective in insulin-
resistant diabetes and to show antihypertensive effects. Photooxidation of troglitazone 
gave the yuinone and cluinone epoxide as the major final stable products. Only the 
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chroman ring of troglitazone reacts with and quenches singlet oxygen significantly, 
and its reactivity and products are analogous to those of alpha-tocopherol. 
Photooxidation of the ophthalmic drugs pindolol "` (1-[IH-indol-4-yloxyl]-3- 
[isopropylamino]-2-propanol) and timolol (S-[-]-1-[t-butylamino]-3-[(4-morpholino- 
1, 2, 5-thiadiazol-3-yl) oxyl]-2-propanol) in water has been peribuned by LC-MS. 
The mechanistic pathways involve singlet oxygen attack to the pindolol indole ring 
and oxidation of the pindolol isopropyl or timcilol tcrbutyl methyl groups. 
The final degradation product fonned in papavcrine solutions in either water or 
chloroform was found to be a 2, 3, 9, 10-tetramcthoxy-12-oxo-12H-iudolo [2, 1-a] 
isoquinolinylium salt (a dibcnzo [b, g] pyrrocolonium derivative) which is formed 
from papaverinc oxidation products that is papaverinol, papavcraldine, and 
papaverine-N-oxide under the influence of U V light X63  
The clomipramine 164  in phosphate buffered (pH 7.4 and 6.0) solution and in methanol 
under aerobic condition was found to photodegrade to six different photoproducts. A 
radical mechanism with the participation of the solvent is proposed for the 
photodegradation of which undergoes hemolytic cleavage of the carbon-chlorine bond 
and also photooxidation of the amine group. 
Triamterene 165 (188) is commonly used as a potassium-sparing diuretic that inhibits 
sodium resorption and potassium secret ion in the distal tubule, is photolabile under 
aerobic conditions and UV light and produces one photoproduct (189) (Scheme 1.57). 
Photochemical properties of Bumetanide 161 (190), a sulfonamide diuretic drug have 
been investigated it has been found the photoproduct obtained as (191), (192), (193), 
(194) (Scheme 1.55). 
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Anti-asthmatic and antidepressant dries: 
The anti-asthmatic drug seratrodast 1b ' (195) undergoes Photodegradation in different 
solutions afford three major products (196, 197 and 198) in methanol, while only two 
of them (197 and 198) could be detected in acetonitrile solution(Scheme 1.59). 
Citalopratn (199) is one of the most widely used antidepressants for the treatment of 
anxiety, obsessional, and control disorders, underwent photochemical transformation 
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in alkaline solution resulting the formation of two photoproduct as N-
desruethyleitalopram (200) produced by N-demethylation as a major product and 
Citalopram 1V-oxide (201) by N-oxygenation as a minor product "' (Scheme 1.60). 
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Irradiation of trazodone (202), a largely used anfideprcssatrt at 310 nm in water has 
been investigated. Presumably produced three photoproducts. Firstly formed product 
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(203), produced by the photoionization of the benzene ring is the primary 
photochemical process, followed by the nucleophilic attack of the solvent to the 
radical cation and loss of HCl. Product (204 ) and (205) are formed from product 
(203). Product (204) is produced by a peculiar dimerization of the dihydropyridine 
moiety 169 (Scheme 1.61). 
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H,1G-CoA reductase inhibitor dru.s: 
Irradiation of rosuvastatin l ' (206), a HtIG-CoA reductase inhibitor drug in water by 
sunlight or UV lamp (Pyrex) afforded three photoproduct as (207), (208) and (209). 
The main photo-induced reaction is cyclization of the drug to give diastereoroeric 
dihydrobenzoquinazolines. Products derived from side-chain loss were also obtained 
in the irradiation mixture, and characterized as dihydrobenzoyuinazolroe and 
benocluinazoline (Scheme 1.62). 
Another drug of the same class glenvastatin (210) is photolabile under aerobic 
condition led preferentially two main photoproducts as (211), (212) the photoproduct 
formed as the heptane chain of (210) is oxidized and its cyclization takes place with 
55 
formation of two diastereoisomers containing three condensed rings ~'~ (Scheme 1. 
63). 
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A collection of examples from literature are presented here to highlight the 
researches on photosen.siti; ink phototovie drugs for their mechanis,n of 
photodegradation and its correlation to phototoxicity. 
Dili droprredines 
Amlodipine 172 (213) belongs to a class of drugs called calcium channel blockers 
demonstrate phototoxicity. When the drug in water was exposed to sunlight the only 
photoproduct (214) was found. Formation of this product was explained on the basis 
of a radical cation intermediate formation through photoinduced electron transfer 
mechanism (Scheme 1.64). The intervention of radical in it suggests that drug has 
(211) 
O 	OH 
0 
OH 
CH3 
N CH3 
F 
phototoxic effect. 
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Irradiation of 4-oxo-2, 2, 6, 6-tetramethylpiperidinyl-1-oxy radical (TEMPO), a 
nitroxide, with 4-substituted Hantzsch 1,4-dihydropyridines (DHP) in CH3CN, gives 
aromatic products through a photoinduced electron transfer mechanism 1 " (Scheme 
1.65).The generation of radical in the photodegradation pathway is responsible for 
the observed phototoxicity of this drug. 
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Nimodipine and felodipine (217) are calcium channel blockers of the second-
generation of 1, 4-dihydropyridines (1,4-DHPs), which are widely used as 
antihypertensive drugs its reaction with singlet oxygen result in the formation of 
dihydropyridine localized triplet or to pyridine derivative as main photodegradation 
product (218) produced by intramolecular electron transfer via a zwitterionic 
biradical intermediate 1'4 (Scheme 1.66). Reaction of singlet oxygen with two other 1-
4 dihydropyredines derivative nifedipine and nitrendipine was studied. Which follows 
similar mode of action ''' as described above (Scheme 1.67). The phototoxicity of 
these drugs involved type —II photodynamic action. 
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Nonsteroidal anti-in l7arnniatmv druyes: 
Carprofen (219) is a photosensitizing nonsteroidal anti-inflammatory drug. It 
undergoes photodecholorination from its triplet excited state and gave photoproduct 
(220). The resulting aryl radical is able to abstract hydrogen atoms from model lipids, 
mediating their peroxidation by a type I mechanism. This aryl radical intermediate 
appears to be responsible for the observed photobiological effects of carprofen 176 
(Scheme 1.68). 
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Indoprofen ''' (221) is a nonsteroidal anti-inflammatory drug (NSAID) which was 
used in the treatment of both osteoatthritis and rheumatoid arthritis and exhibited the 
phototoxic effect. irradiation of indoprofen in aqueous buffer results in 
photodecarboxylation and leads mainly to four oxidative photoproducts whose 
proportions increase with increasing oxygen concentration. The mechanism outlined 
in scheme 1.69. The phototoxicity of this drug have been proposed to occur through 
type —I mechanism. 
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Red blood cell lysis photosensitized by phototoxic drug naprexen 178 (226) was 
investigated. The irradiation of deaerated solutions of naproxen underwent a 
decarboxylation process via intermediate radicals, while under aerobic conditions 
photo-oxidation leading to the photoproduct 6-methoxy- 2-acetonaphthone (228) 
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occurred. A molecular mechanism involving free radicals and singlet oxygen as 
important intermediates and consistent with the overall results is proposed (Scheme 
1.70). 
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Red blood cell lysis photosensitized by photosensitizing drug suprofen ti9 (229) and 
the photolysis of the drug were investigated. Photolysis of the drug at 310-390 mu in 
deaerated buffered solutions (pH 7.4) leads to a decarboxylation process with the 
formation of p-ethyl phenyl 2-thienyl ketone (230), whereas in aerated solutions 
formation of photoproduct I and of the photoproducts p- acetyl phenyl 2-thienyl 
ketone (231) and p-(1-hydroxyethyl)phenyl-2- thienyl ketone (232) occurs. The 
overall results of SPF photodegradation and a hemolysis demonstrated that cell 
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damage is provoked principally by the direct attack of drug radicals and secondarily 
by singlet oxygen and hydroxyl radicals (Scheme 1.71). 
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The lysis of red blood cells photosensitized by diflunisal 1°0 (233) was investigated. 
Direct irradiation of DFN in buffer solution at pH 7.4 leads to the formation, under 
anaerobic conditions, of compound 2'-(2"',4"difluoro-3"-carboxy-J I", I "`-biphenyl] 
4"-oxy)-4'-fluoro-4-hydroxy-[ 1, 1 -biphenyl] -3-carboxylic acid (234), whereas 
under aerobic conditions formation of (234) is accompanied by unidentified photo-
oxidation products; only compound (234) displays strong lytic activity. The overall 
results for (233) photosensitized hemolysis suggest a mechanism involving a 
concerted action of free radicals, superoxide anion, singlet oxygen and sensitizer 
photoproducts (Scheme 1.72). 
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The novel anti-inflammatory drug benzydamine 181 when irradiated in aerated 
solution, competing pathways of photosensitization are possible, namely, singlet 
oxygen mediated oxidation, and electron-transfer mechanisms. The ability of 
benzydamine to participate as sensitizer in several types of photochemical reaction is 
relevant to the observed clinical photosensitivity of the drug. 
The phototoxic drug thiocolchicoside 182 (2-dimethoxy-2-glucosidoxythiocolchicine), 
is photolabile under irradiation with UV-A light in aerobic and anaerobic conditions. 
Irradiation of a methanol solution of thiocolchicoside produces two photoproducts 
without a glucoside group. One of these lost the methylthio-group, while the other is 
oxidized (only under aerobic conditions) to sulfoxide. Thiocolchicoside was screened 
in vitro in different concentrations for UV-Vis-induced phototoxic effects in a 
photohemolysis test, in the presence and absence of different radical scavengers, 
singlet oxygen and superoxide radical quenchers. Studies on peripheral blood 
mononuclear cells (lymphocytes) demonstrated phototoxic effects on them. Protection 
by GSH, DABCO, sodium azide and SOD are indicative of both Type I and II 
photosensitization pathways mediated by free radicals and singlet molecular oxygen. 
. t iItiireoJ1a.stic druts: 
Tirapazamine (235) a potential antiturnor phototoxic agent has been found to be 
capable of acting selectively in hypoxic environment found in rapidly growing 
tumors. One of the proposed mechanisms of action of this compound is shown in 
Scheme 1.73; enzymatic electron transfer and subsequent proton transfer to generate 
the radical, which undergoes n-fission to generate 3-aminobenzo-1, 2, 4-triazine- :V-
oxide (236) and hydroxyl radical, which is well established as a promoter of nucleic 
acid cleavage(phototoxicity) is3 (Scheme 1.73). 
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The phototoxic anti-cancer drug flutamide I-S4 (237) is photolabile under UV-B light in 
either aerobic or anaerobic conditions. Irradiation of a methanol solution of this drug 
produces several photoproducts, one by photoreduction of the nitro group, one by 
rupture of the aromatic-NO bond of the parent compound, two as a result of the 
rupture of the CO—NH bond and one derived from the photoreduction product by 
scission of the aromatic-NH2 bond. The phototoxicity of flutamide was shown to 
occure through radical mediated (type-1) process (Scheme 1.74). 
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Decarbazine is clinically effective in the treatment of several malignant disorders, 
including metastatic malignant melanoma, Hodgkin's disease and soft tissue 
sarcomas, in combination with other anticancer drugs. This drug induces 
photosensitizing effect in patient treated with it. On UVA-irradiation photoactivated 
decarbazine generates the carbene and aryl radicals, which may induce both DNA 
adduct and 8-oxodG formation, resulting in photogenotoxicity Iss. 
A spectroscopic study of irradiated photosensitizing drug camptothecin 186 in the 
presence and absence of copper has been performed to explore and identify the radical 
species generated in these processes. The reported result indicated that camptothecin 
is a promising photosensitizer and that radicals and singlet oxygen generated upon 
illumination play a central role in DNA cleavage and in the induction of apoptosis in 
cancer cells 
Diuretic and Anti diabetes drues: 
The phototoxic diuretic drug furosemide "' (242) is photulabile under aerobic and 
anaerobic conditions, irradiation of a methanol solution of 242 under oxygen 
produces photoproducts (243), (244), (245) and singlet oxygen, while under argon the 
photoproducts (243) and (245) were isolated. The result indicated that phototoxicity 
mechanism for this drug most probably involves reactions of singlet oxygen and 
superoxide oxygen with cellular components than reactions of a free radical 
intermediate or stable photoproducts (Scheme- L75). 
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The phototoxic diuretic drug acetazolamide 1148 (246) is photolabile under irradiation 
with UV-B (at 300 nm) light in aerobic condition also photodegradation of (246) with 
UV-A light (at 337 nm, N2 laser) and photosensitizing degradation with rose bengal 
was observed. Two photoproducts were isolated and identified. In both the cases the 
same photoproducts were obtained. Sensitization reaction involving singlet oxygen 
lead to decomposition of acetazolamide. Acetazolamide has been shown to 
photosensitize the reduction of nitro blue tetrazolium in PBS, which is more efficient 
in deoxygenated condition and quenched in presence of SOD. These results indicate 
that direct electron transfer occurs from the excited state of (246) to the substrate, and 
also that superoxide could be involved as an intermediate when oxygen is present 
(Scheme-1.76). 
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The antidiabetes drug gliclazide 189 (249) is photo labile under aerobic condition and 
UV-B light. Irradiation of a phosphate buffered solution of gliclazide under oxygen 
atmosphere produces two photo products as (250) and (251). The photochemistry of 
(249) involves cleavage of the S-N and C (0)-N bonds (Scheme 1.77). The reported 
result indicated that gliclazide have shown radical mediated (type-f) phototoxicity. 
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Antibacterial and antiviral drues: 
The photochemical reactions in vitro of antibacterial drugs sulfamethoxazole alone 
and in combination with trimethoprim have been studied to obtain information on the 
photosensitization mechanism. Sulfamethoxazole in aqueous solution, on exposure to 
UVB radiation, generates free radicals and singlet oxygen, with the neutral molecule 
being at least twice as active as the sulfamethoxazole anion. Photoexcited 
sulfamethoxazole can participate in electron transfer to cytoehrome-c and nitro blue 
tetrazolium, and sensitizes the peroxidation of linoleic acid and the hemolysis of 
human erythrocytes, predominantly by a free radical mechanism. Trimethoprim is 
relatively inactive in the same photochemical systems 19U. 
Amodiaquine NI (252), an antimalarials drug possess undesirable photosensitizing 
properties that produce phototoxic side effects in both the skin and the eye. UV 
irradiation of amodiaquine leads the formation of photoproduct produced through 
concerted cycloaddition of singlet oxygen to the aminophenolic ring of this drug 
(Scheme 1.78). The study indicated that singlet oxygen formation account for the 
observed phototoxic effect of this drug. 
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Vasorenulator drugs: 
The potential phototoxic activity of naphazoline 192 (NP), 2-(I-naphthylmethyl) 
imidazolone (253), belongs to the vasoregulator class of drugs was investigated by 
studying its photoreactivity towards DNA. Photocleavage studies combined with laser 
flash photolysis experiments provide clear evidence that the transient species 
produced under NP photolysis react with DNA, thereby promoting its breakage under 
both aerobic and anaerobic conditions(Scheme 1.79). 
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Beta-blocker drug: 
The photochemistry of phototoxic drug propranolol (PR), 1-isopropyl amino-2-( I - 
naphthyloxy) propan-2-ol (254) belongs to a wide group of drugs classified as beta-
blockers, has been studied. PR photodecomposition takes place in an aerated aqueous 
medium and leads to 6-hydroxy-1 ,4-naphthoquinone (255) as the sole stable 
photoproduct. Formation of this photoproduct demonstrated that photodegradation 
occurs via a type II mechanism involving irreversible trapping of self-photogcnerated 
singlet molecular oxygen 193 (Scheme 1.80). 
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Lipid-lowerine and Anaesthetic aeents. 
Atorvastatin calcium 196 (256) is one of the most frequently prescribed drug 
worldwide. Among the adverse effects observed for this lipid-lowering agent, clinical 
cases of cutaneous adverse reactions have been reported and associated with 
photosensitivity disorders. On the basis of the obtained photophysical and 
photochemical results, the phototoxicity of atorvastatin can be attributed to singlet 
oxygen formation with the phenanthrene-like photoproduct as a photosensitizer 
(Scheme 1.81). 
The phototoxie HMG-CoA Reductase Inhibitor drug fluvastatin 195 (260) underwent 
rapid photodegradation upon Ultraviolet-A (UVA) irradiation in buffered aqueous 
solution to give benzocarbazole-like photoproduct (261). The phototoxicity of 
fluvastatin may be mediated by the formation of benzocarbazole-like photoproduct 
that acts as strong photosensitizer (Scheme 1.82). 
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The phototoxic anti-hyperlipoproteinemic drug fenolibratc "9b was found to be 
photolabile under aerobic and anaerobic conditions. Irradiation under argon of a 
methanol solution of this drug produced the photoproducts isopropyl 4-(1-[4- 
chlorophenyl]-],2-dihydroxy) ethylphenoxyisobutyrate, 1,2-his (4-chlorophe vl)- 1,2-
his (4-[isopro-poxycarbonylisopropoxy] phenyl) ethane-1,2-diol and 4-(4- 
chlorobenzoyl)phenol, while under oxygen the photoproducts were 4- 
chloroperbenzoic acid, methyl 4-chlorobenzoate, 4-chlorobenzoic acid and singlet 
oxygen. In summary, fenofibrate is phototoxic in vitro. This behavior can be 
explained through the involvement of free radicals, singlet oxygen and stable 
photoproducts. 
The reaction between the anaesthetic agent 2, 6-diisopropylphcnol (propofol. PPF, 
262) 197 and singlet oxygen ('02) has been investigated in aqueous solution. The 
reaction of propofol with singlet oxygen produced by light irradiation of rose bengal 
leads essentially to two reaction products, 2,G-diisopropyl-p-bcnzoquinone (263) and 
3,S,3,5'-tetraisopropyl-(4,4')-diphenoquinone (264) ( Scheme 1_S3) 
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Antidepressant and .4itiplatelet druL's: 
Lamotrigine 	an anticonvulsant and antidepressant drug produces a (photo) toxic 
response in some patients. Lamotrigine absorbs UV light, generating singlet oxygen 
( 1 02) small production of superoxide radical anion was also detected in acetonitrile 
Thus. Lamotrigine is a moderate photosensitizer producing phototoxicity and 
oxidizing linoleic acid mainly by the contribution of singlet oxygen. 
The photochemical reactions of dipyridamole (265), a healing agent were studied. Its 
photolysis product under UV-A and aerobic conditions was isolated as (266). The 
photodegradation of dipyridamole occurs probably via a type II mechanism involving 
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irreversible trapping of self-photogenerated reactive oxygen species (ROS). The 
formation of singlet oxygen and superoxide during the dipyridarnole 
photodegradation makes one suspicious of a possibility that dipyridamole could also 
be involved in oxidative stress in biological systems 99 (Scheme 1.84). 
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Triflusal is a platelet antiaggregant drug '110 with photoallergic side effects. However, 
it is considered a prodrug since it is metabolized to 2-hydroxy-4- 
trifluoromethyibenzoic acid (267) the pharmacologically active Form. (267) was found 
to be photolabile under various conditions. Its major photodegradation pathway 
appears to be the nucleophilic attack at the trifluoromethyl moiety. The photobinding 
of (267) to proteins such as bovine scrum albumin has been demonstrated using 
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ultraviolet—visible (UV—Vis) and fluorescence spectroscopy. Nucleophilic groups 
present in the protein appear to be responsible for the formation of covalent drug 
photoadducts, which is the first step involved in the photoallergy shown by triflusal 
(Scheme 1.85) 
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The pholodegradation of photosensitizing antidepressant drug clomipramine 201 in 
phosphate buffered (pH 7.4 and 6.0) solution and in methanol under aerobic condition 
was studied. Six compounds were identified and four of them were isolated and 
characterized by spectroscopic methods. A radical mechanism with the participation 
of the solvent is proposed for the photodegradation of clomipramine which undergoes 
homolytic cleavage of the carbon-chlorine bond and also photooxidation of the amine ... 
group. A mechanism involving singlet oxygen, radicals and photoproducts is 
suggested for the reported phototoxicity of this drug. 
Ainitriptvline 	(269) is a tricyclics antidepressant drug. This drug induces 
photosensitizing reactions in humans, as an adverse effect .Upon UV-A irradiation it 
photocheinically transform into photoproduct (270) and (271). The phototoxicity of 
amitriptyline can be attributed to radical formation via Type I mechanism (Scheme 
1.86). 
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The photochemistry of pharmaceuticals is an area of growing concern as the number 
of drugs found to be photosensitive-phototoxic is increasing. Since all the adverse 
photobiological effects produced by photosensitizing-phototoxic drugs are the 
consequences of photochemical reactions, it is important to stimulate more chemists 
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to work on the molecular basic of photobiological problems. The dated interest of 
photochemists in the properties of the electronically excited states of compounds of 
pharmaceutical use has been rapidly increasing during the last decade. This is not only 
connected to the increasing number of cases of drug-photoinduced disorders, but it 
has also attracted considerable attention from a more fundamental photochemical 
standpoint. Thus, it is worthy to stress that studies performed on drugs bearing either 
simple or complex chromophoric structures have provided remarkable contributions 
to the broad area of the molecular mechanisms of photo-initiated reactions. Therefore, 
herein in the following chapters we have carried out in vitro photochemical studies on 
some photosensitizing drugs. 
References 
1. 111111 !' wwcv.Pol-us.net/AspHomelaspbr02.htnil 
2. Sunlistht, CItraciotet Radiation, and the Skin, NIH Consens Statement 
19R9 May. 7, I 
3. R. A. Larson. Phvmchemisn.r, 1988, 27, 969. 
4, J. P. Knox_ A. D. Dodge, Plrnrochemistrv, 1985, 24. 889. 
5. http:/twww. Chem,ucla.edaidept/organic/ CSF_Brochure.html. 
6 D Saha. A. Tarnrakar,Asiun,7. Res_ Phornw Sc!. 2D11. L 36. 
7. G,M.J_B jvrsbergen 'an Hetiegouwen, J.Ptiotochern_ pdotubioI13: Bin!, 1991, 
10, 132_ 
8. A. R_ Wielgus, J. E. Roberts, Photochem. Photobiol, 2012, 88, 1320. 
9. S. Onouc. Y. Tsuda. Phorm Res. 2006. 23, 156. 
10. M. A. Miranda, Pnre,4pph Chew, 2001. 73. 481. 
II M. H. Kleinman, M. D. Smith , E. Kurali. S. Kleinpeter [C. Jiang Y. Zhang S. 
A. Kennedy-Gabb, A. M. Lynch, C. D. Geddes, Regtd, Tosicol. Phurwacal. 
2010.58, 224. 
12. V. Lhiaubet-Vallet, MA. Miranda. Pure 111111. C7rr'm., 2006, 78. 2277. 
13. G. Cosa, Pure Appl. Chem.. 2004. 76. 263. 
13. R.K Murray. D.K Granner, PA Mayes, V.W Rodwell: Hwper'c 111n,nurrd 
Biochemirbv, 27 1`1 ed. McGraw-Hill Professional, New York 2006. 
I3. J. Jakus, 0. Farkas. Plruroehc'u, Phutubiai Sc]. 2005, 4_ 694. 
16. D.Budac, P.Wan.1 Photochetn_ plaotobio/.A: ('hruj, 1992 ('7. 135. 
1 	\ I. M A. Nil r,tnda..1.1'ht /1t 1 ,. llwh„bivl. B Pu ii. I ~~x. 43- I 
1 S. S. Sortiltu. (i. Cosa. 1. U. Scaiano..\'c'►► .1. ('hr)n., 2(1)1). 24. 1 59 
19. S. Sort mo. .1. U. Scaiano, S. ( ilut'Mridl,.V 'it J. f'hrnl.. I999. 23. 1159. 
20. S. ( )noue Y. Seto G. (iancly S. Yamada. C'lr Uru, S'uf. 2O09. 4. 12 1. 
21. H. 11. I unnesen. in: Photostability of Dru~U, and 1)ru_ Formulations. II. 11. 
i onnesen Ld.. l'avlor and Francis, 1.onclon. 1996. 
22. L).F `loore. /)riig Sal. 2002. 25. 345 
23. N1.R.Blialckar. D. Harinaravalla. A. R. .\lad ulkar, S. .1. Panclva. 1). K. Jain. 
. l ciml J. ('hell). 2008. 20. 5095. 
24. K..\. K. Mlusa. L. A. 1:riksson, .1. 1'1)i'... C hem. R. 2009. 113. 1 1306. 
25. ( . ('ondorelli. L. l.. ('ostanzo. (i. De Guicli, S. Giufi'ri(la. 1'. Miano. S. Sortinu, 
.\. Velarclit i. /J1 Ncit.,l.. 1990, 58. 60. 
16. Sym11posiuI11-In-print on Drugs: Photochemistry and Phototoxicity. S. Monti. 
(Ed.) 1'l)c,luc'l)c'l)1. Phot ,h1(ll. 1998. 68. 633. 
27. M. A. Miranda. Phototoxmcity of drugs, in In vitro Methods in Pharmaceutical 
Research. .J. V. C'astell and N'1. .1. (Jomez-Lechon (Eds.). 1997. pp. 289-215. 
Acacienlic Press. London. 
28. S. Sorlino. S. Giuff'ridla..1. U. Scaiano, Chen. Res. %',.vicc,l. 1999, 12. x)71. 
29. S `lontanaro, V. Lhiauhut-\'allet. Ni. Rosaria Iesce, I.. Previtcra. M. A.N1irmlcia, 
('lu i,i. Rc.s. %O-V- /(u1. 2009. 22, 17 ;. 
'0. J. \. Greenhill, M. A. \1cEeliahcI, /'i'oi. tied. ('Drl11., 1990. 27. 5I. 
31. 1). F. Moore, .l. 1'l)cirm. Biometl. . in I., 1987, 5, 4.1. 
~:'. I. \ .0 _:i:. ( 	Rn as. Ni. A. \lirliuI i. I. l .*a. l'hurnrct_ie. I9 I. 46.767. 
. t=. E 	Ni. .\. Miranda. I.. \'anv. V. \',u-ga•..1. Photuc.'/rk't1. f'IU)h,hiOl.. .-i. 
( hcm. 1990. 54. HI 
4. 1). F- \b ore. .t1ll!LIt.I?. . 	9O5 422. 1O~. 
5. NI .;\ Miranda, I'hOOtOtOXicitV of clruC>. In lit 1 itrn Akthncl\ ill Phuu -nruc•c'll(iccrl 
Rc.,wa -c h. J.V. C'astc:ll Ed. pp. 289- 31 S..Academic Press. London. 1997. 
:(,. J.D. `hikes. Photosensitiiation. in Smiths. K.C. (Ed.), the Science cat 
Photohiologv. pp. 71)- 1 I0. New York: Plenum Press. 19N9. 
37. R.\ Bensasson. L.J. Land. I .G E ruscott. Hash Photolysis and Pulse Racliolvsis 
1)1). I -- 19. ( )x ford: Pcr-`'anuo►n Press. (I 983). 
8..1.(i. (. a1' cit.J.N. Pitts. Experimental methods in photochemistry. in 
Photocheinistrv. pp. 783 804. tie York: John \Vile ' & Sans. 1966. 
9. A (iilhert, .1. Batcott. Essentials of Molecular 1'hotochemistrv. pp. 145 228. 
oxford: BIackv ell. (1991). 
40. K. A. K. Musa, E_.:\. Eriksson.I. Phis. Chem. R, 2009, 113, 11306. 
41. [lashiba. Ni. l utsuza% a. A. I;i/mu. Eiscei Shikeus'hu 1lukuktr, through Chem. 
\hstr.. 1980. 93. 16854n. 
42. M. Ehat,:\hc1eI-Nroc:tv. Ni. A. lhrahim. Ni. R. Reik., Spec•ttuchinucu . lcta Purl 
..1. 2(M)9. 74. 740. 
4. I. M. (lien. .\. D. Si II. U. L. Iloustuver, J./'hwrnr. Kio llh-i..lnul., 1986. 4. 53 
44.:\. R. E3reier. N. S. \ucde1man. NI. S. E1iiticic;•, E. S. Schahoual,J.P/uimr. 
llUutt Ll_ . mat. 2nt►~. 46. 25n 
t:S. F. \ar i. ('. Riv;i.. \1..\. \1ircincla. F. [3wca. /l,t,r,rram, lc)c)1.46. 767. 
46. D. F. \lucre. 1'. P. ('happuis. l'hc,tc,c /u nl. l'hc,to/no .. I 	47. 173. 
4-. (i. ('Onclr►rcaii. (i. l)c: ('iuicli. ('J. Ciiulrid t. L. 1_. (ostanzu. (' i rcl. ('lien,. lRc~".. 
'-N'. 125. 115. 
4. 1). Uuciar. 1'. \1'an..1. Photoclrc'nr. P/,oiahic,l. 1992. 67. 1 35. 
4.). K. KL,ika. C. F. (1' nel. 	 PIfVI)hi)l. I 1)M;. 3$. 2~1. 
50. I. V. ('astcll. \1..I. ( iomez-Leehoii. `1..\. Miranda. I. M. Nli rr<a. l'latoc•hani. 
1'llol~,hi(~l.. 19' '. 46. c)c) I 
5 I . I. V. Castell. NI. .1. (k met-1 _cchon. \1..\. Miranda. .1.1'I)t(c/eru. 1'hotuhiol. B: 
Bic,l.. 1 x)92. 13. 71. 
52. S. Monti. S. Sc~rtino. (i. Dc ( iuicli. (I. Marconi. .1. ('hrnr. Soc. /''uncle - Trans.. 
19i'. 93. 2209. 
53. I. [3OSCa. M. A. Miranda. G. ('ai Ini'c. [). Mauloon. 111010 /1cin. P1r1o/)iuI, 
1994. 60. 96. 
54. 1. V. C a,tc1. NI. S. ( 	ci-l.c~hon. C. Ciras:a. I.. A. Martinez. M. A. Miranda. P. 
1'/rc,toc I7unr. /'lr)tc,hio/. 1994. 59. 35. 
55. S. \:t 'ua1n.tm. .3. 1 . Ehi.`:hes. B. J. Parsons. G. 0. Philips. P/zotoc/ohr. 
I'/luto,hiel, 	41. , 75. 
56. F. 13osca. M1..\. Miranda. F. Vargas. .1. Phan,,. Sci.. 1 992. K 1. 1 ,S I 
57. I.. ( iu. II. S. ('hiang. 1)..Iohn:c,n. I,rt..1. /'hur,n.. 19 'S. 41. I O>. 
SS..\. C. \1'ccdon, D. F. \\any„ .1. I'/iotoc/il'in. I'huluhiul... I: ('/tc'„r., 1991. 61. 27. 
). R. 1) thcau. 1<. II. ail.. 1). (. I):r\ t. (i. I)uha. C. F. ('hiwrdll. /',~ , ~~ h( I(I. 
Yl,GtOI ,IOT. I9c)?, 58. _x67. 
(di. ,\. I. \1 u. If. \V. (hen,.'. U. M. I Iu. F. A. ('hen. I. U. ('hou. U. Y. ( hen. 
/( !i'(rlrc'(lr(,ir l.ern.. 1997. 38. (~2 I 
61. I. Eriksson. J. Svanfelt. L. Kronherg. l'JrulC,chanr. l'hotohiol. 20I0. 86.5 8. 
62..1. Philip. D. II. Siulcie'\ ski. .1. /'/paim. Sc i.. I97. 62. 1479. 
63. F. Vargas. C. Rivas. R. Niachacic,, %. Scrrahia..1. lhu ni. Sc i.. 199 ;. 82. ',-1 
64. J. V. C'astell. M1..1. (ic,mei-1.echc,n. V. Nlirabet. M. r\. Miranda, I. M. `lc,rea..1. 
/ /,ar,fl. Sc•i. . I 987. 76. 374. 
6~. 1..Iensen. (. C'orncat. ('. I. ( )I.crn..1. 1.hicrne1and. S. ii. I Larsen. Jut. .1. l'har,n.. 
9Q2. 88. 177. 
6(,..1. Re isch. L. Iransharti, N. Lkiz-(iuecer. Liehigs ;inn. ('hc•nl.. 1992. 5. I I c)c) 
6''. C. 1. Lin. 1'. Perrier. ( i. (1. ('lay. 1) A. Sutton. S. R. E3yrn. .1. Ors.;. ('li iu.. 1982. 
47. 2978. 
68. K. Shai her, M. )emuth. in: Rearangements in the ground and excited state. I. 
I)e Mayo Ed.. Acadoiiic Press, Ne\\ York, IOSo). 3. 281. 
69. 1. Iliclaka, S. llu-iorvi. S. yamaki. M. Shiraffshi, I1. `linato, Yrkugaku La.s.c/ti, 
1950. 100, T_'. 
70. K. I homa. R. Kerker. U. \VcffssbaeIr. l'harirr. hrd.. 1987. 49. 961. 
71..1. Iyhal..\. Gupta. A. I iii :rirn..1z•kiu(,c . 2006. (xi ►. 91. 
72..I. Iclhal. A. Flu;ain, A. Gupta. ('/rear. /'huffs,. Bull.. 2006. 54. 8 S. 
73. (1. MIoIo. S. ( - ,Ittieri , 1). [)aii.uhpc, . l . (io . L. l ;I;an . (;.!x•1.1. 
E3eucrshergen vcut I lCIiCt1OU\V-c:n..1. I'hc,tng!rc'►►r /Viot/io/ B-llw/ 2O I I. 103 , 35. 
74. B. barcislev, M. S. Smith. B. H. (iihhc,n. (),,~. Bionu 1. ('hc'►►r.. ?()10. S. 1876. 
75. S. ('allieria. S. I). ;\cclua. I. C'a,ta2Tiot,!t,, 1'. Brunb. G. Mic,loa.,././'hu►►rm. 
/3io117c'cl. .-lna/. 2U08. 47, 77 1. 
76- K. Jochvm. H. Barton. J. Bojarski. P/uiuinazia. 1988. 43. 623. 
77. 1-I. Barton. .1. 13ojarskr, J. Mokrosz. 1 ei; -clhc'h-►'! l.tt. 1982. 23. ? 133. 
78. II. Barton. L. Alexandra, .1. Bo,jarski. W. Wclna, 1'har►►►c►_ie. I98 ;. 38. 268. 
79. 1I. Barton, .1. F3c,jarski, A. Zurowska. :1,h. I'hcir►►r. /k - ii,n;ri,,;. (icr.). 1986. 319. 
457. 
8(). .1. N1ol:rcw. A. Zurowska..1. 13o arski. P/c,rmu:m, 1982. 37, ti 32. 
1. 11. Barton. .1. \lokrosz..1. 13c,jarski. NI. Khmciak. 1'hcn•n►c►_ie, 1980. 35. I55. 
82. N.1. 11. Paluchowska. I I..I. Bojarski.. lrch. /'barn,. (If cin/u'm). 1988, 321..34 3. 
$_:. A. Maquile. S. Salembier. M. Hercnt, .I.L. Habib Jiwan,./. l'hnioclhas► I'Iu.go/,io/ 
1-( 'hem. 2010. 214, 224. 
84. R. Skihinski, J. 1'hurm. Bio,nccl. Anvil.. 201 1, 7, 23. 
$5. 1'. Pietta. A. Rav a, P. A. Biondi. I. ''hleniatcl,r, I9$ I. 210. 516. 
86. \V. A. Al-Turk. 1. A. Majeecl. \V. .1. Murray, D. W. Newton. S. Othman, Int..1. 
Plim•n►.. 1988. 41. 227. 
$7. ( i. S. Sadana. A. B. (ihogare. hit. J. /'/to -►;;.. 199 I. 70. 195 
8$. Ni. U. Bcnieronn. G. Mellerio. P. (iiunchedi. C. ''cnranse1a2 U. C'c,nte. 1,,!. 1. 
Phclnv.. 1992. 87. 133. 
Vii 
89. L. J. Nunez-Vereara, C. SunkcL J. A. Syuc!la J_ Phroni. Se.. 1994. 83, 502. 
90. A. L. Zanocco, L. Diaz. M. Lopez, L. J. Nunez-Vergara, 3, A. Squella, , J. 
Pharnr, Sci., 1992. 81. 920. 
91. G. loele. F. Oliveriu. 1. Andrea. M. D. Luca, NI A_ Miranda, G. Ragno,J. 
Photochenn Phnlobiol A-Chem_ 2010, 215, 205. 
92. M. S. Suleiman, M. E. Ahdulhameed, N. M. Najib, H. V. Muti. hie .l fhurur., 
1989, SO. 71 
93. V. Andrisano, P. Hrelia, R. Ciotti ,A. Lconi , V. Cavrini,. PhWnr_ horned 
Anal, 2001, 25, 589. 
94. N .JamiI, H. Afmzrizvi, I. Ahmed, A. Juzheg. J'/jecniru-Eo. 1983. 38, 467. 
95. G. E. Wright, T. Y. Tang, J Phm rrar. Sri., 1972, 61, 299. 
96. D. E. Moore, J. P7uasu. Sri., 1977, 66, 12K?, 
97. R. Andersin. J. Ovaskainen, S. Kaltia.J_ Phatta. homed Anal.. 1994, 12. 165 
98. R. Andersin, NI, Mwsi laakso, J. Pluto 	Jiinmell. Amif- 1995, 13, 667. 
99. 11. J. Roth. M. Adomeit, Arch. Plrarm. (I3(einheim), 1973. 306, 8R9. 
100. R. W. Busker, G. M. J. Beijersbcrgen van Henegouwen, B. M. C. Kwee, H. M. 
Winkenw hit. J Pha m., I97. 36. 113. 
101_ R. S_ Givens, J. Gingrich. S. Mecklcmburg. Lase J. Phru'm., 1986, 29, 67. 
ID?. A. Bakri, G. M. J. Bcijcrsbcrgcn van Hencgouwen, J. L. Chanah 
Phofuxlermutologi,_ 1935, 2, 205. 
103. P. J. C. Comelissen, C. M. J. Beijersbergen van Henegouwen, K. W. 
Gerritsma. hit. J. F1reuvn., 1979. 3. 2(15. 
VIII 
104- 1- Reisch. N. Ekiz-(iuecer, G. Tewes, Liebig., Ann. Chem., 1992. 69. 
105. P. J. G. Cornelissen, G. M. J. Beijersbergen van Henegouwen. Phcu-m. 
Wcekbad, S'ci. Ed., 1980. 2, 39. 
106. N. S. Nudelman, C. G. Cabrera..l Phnrni Sri. 2002. 91. S. 
107- F. Golpashin. 8. Weiss, H. Durr,;lrch_ Pharm. (Weinhefm). 1984, 317, 906. 
1118. H. C. Chiang- S. J. S. Chen. L. C. Yeh..1 Taman Pharm. Assoc., 1976, 28, 36. 
109. J. Pawlaczyck, W. Turowska, Acla Pot. Phu nr.. 1976, 33, 505. 
110. J. Reisch. D. H. Niemeyer, Arcir. Phm-m. IWeinheinr). 1972, 30S. 135. 
III. F. Fasani, F. Tilocca, A. Albini, Phorochem. Photohio(, 2009. 85, 879. 
112. A. K. Davies. J. F. McKellar, Q O. Philips. A. G. Reid, J. Chem_ Soc. Perkin 
Drans, 1979. 2, 369. 
113. D. G. Moore. M. P. Falon, C. D. Burt. hit. J. Phcrnr., 1983, 14, 133 
114. A. S. W. Li, C. F. Chignell. R. D. I [all, Photuchem. ['Jrotohioi, 1987.46, 379. 
115. J. Reisch, K, G. Wcidmann, t4-ch. Ph(1rm. IWc4nheinj), 1971, 304, 911. 
116. S. 1. M. Mubarak. J. B. Standlbrd. J. K. Sudgen, Pharr. dcta Neh', 1982, 57, 
2'b. 
117. S. 1. YL Muharak, J. B. Standlurd, J. K. Sudgen, Pherrnt .delu Hely, 1983, 58, 
343. 
118. A. B. Narbult-Mering, W. Weglowska,: l crcr Pni Pharm.. 1980, 37, 301. 
119- D. E. Moore. B -I. Wilkins. Radfat. Plrvs. Chem.. 1990.36, 547. 
120. B. J. Wilkins, G. J. Gainsford, D. E. Moore. J. Chem. Soc. Perkin Trans. 1. 
1987, 1817. 
121 1. K. II. Ptertner. .1. J. Daly. /Hr. Ch /in. .Lii. l7. 70. 171. 
122. R. (Id&ev. R. Edwards. .1. /'hunn .Si.. 199 1 .80. 2 12. 
123. I. Ninoiniva. ( ).Yan molt'. Ilt!c' 	1976.   -4. 475. 
24. J. J. Bergh. J. C. 13retenbat.h. P. 1. \\essels. .1. /Vuirin. S'i.. 1)$9. 7, 34$. 
125. B. Quintero. Ni. A. \liranda..try I'/ui,,,ia. 2000. 41. 27. 
126. A. Albini. S. Monti. Ciwn, Soc /cr.. 2003. 32. 238. 
12 - , 7 .  I.. Pretali, E. Fasani. D. Dondi. M. Melia, A. Albini, iet,ihc'/roii I.cti. 2010, 
51.4696. 
I 2S. L. Pasteur. Lonipt. Rnt/.. 1853. 37. 110. 
121). A. Brossi. W . ft ( lessner. U. D. I IutThrd. .1. K. Baker. F. Homo, P. Millet. I. 
Landau. ELB. Lu.. 1987. 223. 77. 
130. S. K..ristensen. A. L. (. risI inguas. .1. V. ( ireenhi II. T. Sketne. .1.  Karlsen. I 1. 11. 
Tonnesen, 1,,!. .1. P/iar,ii.. 1993. 100. 1 5. 
1 31 . J. A. ()wovak. mt. J. !Iu,rm I 989. 56. 213. 
13,21. H. 11. Tonnesen. A. L. (irislingaas. S. 0. Woo. .1. Karlsen. lilt. .1. I'/iw-,n.. 
1988. 43. 215 
1 33. K. Nord. .1. Karlsen. II. II. Tonnesen. lilt. .1. IViarin.. 1991.   72. 11.  
134. .1. A. ()wovale. lot. .1. P/iwi,,.. 1989. 52. 179. 
I 35........Aaron. .1. Fidania. hilaizici. 198'). 29. 238. 
136. H. LI. Tonnesen. A I.. (irislintaas. lilt. .1. l'harnz. 1990. 61). I 57. 
I 	J. K. I lurton. V. I. ( i. Stc cmie.. I. I'iuii',iu. /1111iilcuoI. I )8 1. 33. 808. 
I ,S. :\. I rcclenIiai. n. I . tiCyuin. /l/i. ( /luI.. h in. 1985. 68. ;c)1. 
139. V. J. liemmens. D. E. Moore. .1. C lieii. Snc. T 'c'Aib 7i in.. ', 1984. 20c). 
1-I( 	iupta. S. Ra\\ at. : A. PM1de\ ..1 •iaii .1. !'Yt,M,,,..'l nu. 2O1 1. I. 29. 
141. S. Sortino. ( C. Nlureoni. (C. ( nciurelli. (lie,,,  ( 'ut►Wnri,1.. 2001. 5. (226. 
42. S. Sorting. S. (~iulCricla. G. Dc (iuicii. R. (hillumi, S. f'utralia. G. \~1arcc~ni. (I. 
C'undoreIb, S. Scioto. l'hutWc/Ic•1►r. /lotU/IoI., 2001. 73. 6. 
143. K.:\kiiuotu. A. Kaw ai. K. Ohva. J. C /,ro,,,atogr. A. 1996. 734. 401. 
144. R. I. Frith, Ci. Phillilxou, J. C J!iO llcrtuL'r. 1986. 367. 260. 
145. D. \\. \lendenhall. 11. Kobayashi. F. M. l.. Shill, 1...A. Stcnison, T. Higuchi, 
C. Fabian. C'lin. (*lelrl. 197$. 15 I S. 
140. T. D. Doyle. \V. R. Benson. N. 1:114iescu..1..Ir►i. ('1►errr. Sur.. 1976. 98. 3262. 
147. P. Huelshotcr. .1. Kalvoda. K. Schatfnur. //r/►. ('liul..iciu. 1960. 43. 1 22 
148. T. I). Doyle. W. R. Benson. Ni. Fihpcstu. l'1,c.tc,ihc'lrt. /'1?c,tc,/)it,,., 197$. 27. 3. 
149. A. (i. .I. Seclee. G. M. .1. 13ei.jersheren van Hone ouwen. ..in/,. /'horn,. 
(I e inheino. 198 . 3 18. 1 I 1. 
I 50. A. (i. I. Scdcc. G. M1..1. E3ripersbemucn van HcneguuMven. N. .1. de \1ul. G. 
Lodder. (hen,. Rio!. Interact.. 1984. 51. 
51. .1. Reisch. N. I kiz-Gucc er. (I. Tew e . (;. Henkel, Lic'htgs .41111. (hem., 1989, 
5c)5. 
15?. J. Reisch. N. Ekii.-Guecer. NI. Takacs. _1rch. !',roan►. (Iti'inIeinr). 1989, 322. 
173. 
I 5 . .1. I&eisLh. .1. /.tpcI I. \ I. R. \k iiiptl Ii. ( I. I lcnkel I. / 'IidIifl ..1( 1(1 11cR.. 1994. 
69. 4.)7 
1 4. .1. Rcisch. .1. Zappel. ( i. Flenkcl. N. kkii-Guecer. .tbmat.ch. (hem.. 1993, 124. 
('i 
I 55. J. ReisLIl, N. Fkiz (ueccr. M. Ttkacs. G. I leukel. Lic'higs .I,,,,. (hen'. 1989. 
595. 
156. L. Zanocco. G. S. (iuntIii. I..\1. Lemp. .1k de la luente. \. U. Pizarro. 
11htocIu.'n. 1'/lO(o/)iOI. 199S. 68, 487. 
1 57. Y. Nian Benny Li. 1). F. Moore. B. N. Tattam. hit. J. I'harm. 1999. 183, 109. 
I 58. F. Varias. H. Mendet /)ic /'I,aimu:ie. 1999.   54, 920. 
I3iown. .1. S. 1)eii. .1. 	I 	( in,. /.vicu/. 1995. 33. 729. 
160. L. \lirossay. A. \1irosi . I. Kocisova. I. Radvakova. P. Nliskovskv. J. 
\ lovis. P/i vi1. Re'.. I 999. 48. I 3 5 . 
161. F. Yulaii. C. Sheu. T. iuj ha, C. S. Foote. /'/lutoc/uni I'/u.tohwl., 1996.   63, 
615. 
162. S. Criado. D. N1iriirc P. Allegretti. .1. Furlong. S. Bertolotti• E. La Falce N. 
Garcia P/uirmuic. 2003. 58. 55 I. 
163. 1.. Gji-reser. T. W. 11ernianu. K. Piotrowska........I, I'hwin (iVein/u'im).. 2003. 
336. 401. 
164. N. ('anudis. C. Contreras. 1'/iuimu:ic. 2002. 57. 405. 
16",. Fuentes A. Sequera 1. Mender II. Fraile (i. \eLtsquct M. Medina R. Iv.vhoI hi 
Vitro. QQN. 12. 661 
160J. I-iiii. I. IiI I'll iIini. l. I IicIii. V. \n(Iuisai.. A. Iir&,'./i V. ('a\rii1i. 
I'h,tu&Ju'1?l. I'Ii()!()I)!OL.S(.i. . 200.. 2. MI I I 
167. J. Nu. Y. ZIuu. '' . flu. .1. Pharm. Binned. Mw!.. 2008. 48. Th. 
I (S. .1 	 K. L. .\rnm$. I' 	w Iv.\'ItvI ( 7i',iz 2((tS. 24. 101',s. 
169.M.  1)elIa('irec. M. RsarLI Iesie. I.. Previtera. NI. Rubino. V. Barone. 0. 
(rc.,ceni..1. i>/u,to/u.n,. /'/,,thh'/. 1-('/zeni. 2008.M 	199. I53 
170. A. .Astarita. M. D. (irecJ. M. R. lesce. S. Nlontanaro. L. Previtera. F. Femussi. 
I. P/.toc/Zefll. I/.P((il)iD/. ;l-( izeni. 20(L. 187. 26. 
171. L. Sohotta. P. Kadilicki. L. \Iarczak. M. Krvjevski. .1. Nlielcarek. P/wwc/iein. 
/)/1111/j/• ;l-( /i'ii. -'() 1 I . 224. I 
172. M. 1). ( ireca. M. R. fesce. L. Previteit M. Rubino. V. Barone. 0. C'rescenzi. J. 
PJiot'.Iu'ni. J'IotobioI. .l-( lien,. 20(),. 199. 353. 
173. M. Lu. .1.  (i. Fan. Z. Li Liii. I.. M. \\ u. Chill. Chen. Leu. 2002. 13. 923. 
174. N. Pi,arro.( i. ( iunther J.. .1. N unei.-Vcruara. J. / Vwtoc/u',n. /'/u,tobw/. .1 -C 'lien, 
2005175. 129. 
175. N. Pizarro. G. Gunther. L. J.Nunez-Vereara. I. Pl,otoc/ze,n. I'/zotohio/. .l-C/zc'n, 
2011. 189. 23. 
176. F.Bosca. S. Encinas. P. F. I leelis. Ni. A. Miranda. ('lien,. Res. Io.v,co/. 1997, 
10. 820. 
177.V. I.. \'allet. .1. Fricionka I. S. Enemas. M. A. Miranda, N. Chouini-Lalanne. 
I'/!( (( )!)IH/. 2003. 77, 4S T'. 
xiii 
1 78, U L. Costanzo, G. Dc Guidt, G. CondorelIL.l. PhnlodrdnI Phiolabro(B-Bio!, 
1989, 322]. 
179, Ci. Dc Guldi, R. ChilIemi, 1.-1._ C'ostanzo. S. Giuffrida, S. Sortino and G. 
C'ondorelll, J. Pholochem Phw1ohio1 B-Biel, 1994 ,23 125. 
180,G. De Ciuicli, K. (-:hillem, S. Gitirida, G. Condorelli, M, Cambria Fama, J. 
Pholochem Pholohiol B Biol , 1991 , 10 , 221. 
1 S I.D. E. Moore, J. Wang, J. Photochem. Photobiol. B-Blot 1998, 43, 175. 
182.F ,Vargas IL Mendez , A. Fuentes .3. Sequera , G. Fraile , M V elasquez, G. 
Caceres , K.Cuello, Pharmazie. 2001, 56, 83. 
183J. S. Poole, C, M. Hadad, M. S. Platz, Z. P. Frcdin, L. Pickard, E. Lcvva 
Guerrero, M. Kessler, G. Chowdhury, U. KotaUndeniva, K. S. Gates, 
Photochem.Photobiol.2002,75.339. 
184. F. Vargas, C. Rivas, A. Fuentes, A. T. Chong, G, Vclulini, J P6otochent. 
PhotohiaL A-Ch em, 2002, 153, 237. 
185.T. Iwamoto, Y. Hiraku. M. Okuda, S. Kawarushi, Pharn,accut Res, 2008, 25, 
598, 
186. V. Brezova, M. Valko, M. Breza, H. Morris. J. Telser, D. Dyoranova. K, 
Kaiserova. L. Varecka, M. Mazur. D. Leibfritz, J Phvs. Chern. B, 2003, 107, 
2415, 
l87F. Varga,, 1. M. Volkmar. J. S. H. Mendez, J. Rojas, G. Frailo, M. Velasquez. 
R. Medina, .J. FbnlnebnH PhoJo hit l B- Blot. 1998, 42, 212. 
\l\ 
I 	1 	 V. \ . II 	tI1..1. K. Itcoi as. ./. /'Irc ,tc,c/rc'ni. Pbc,t()/uul..I-('hc'nr. 
1 	11H. 11). 
I 59. F. Varga..('. lzzo.1'. Loltan.V. I.ope7. . l t a/1(r.c in QuiHnatt. 2006. 3. 
190. \V. Chou. 1). 1F.. \tcrrc. J. /'/tulc,ehe'n►, l'hcNr,hic,/. B-Ktc,/, 1997, 39, 63. 
191. 1:.. I.cmh. C. Valencia. A. L. 7anocco. J. l'hU,tOrhrilr. Phc,tc,/)ic,/. ;1-Chcnt. 2004. 
168, 91. 
192. S. Sortino. S. (iiuttrida.l. C. Scaiano. C hem. Re. 7uxicol. 1999, 12. 971. 
19 3. S. Sort ino.S - Petra I la. F. Bosca , MMM..-V .Iirancia, Yhc►lrc/c'nr. Phntob/ol. Sri., 
2002. 1. 136. 
194. S. Montanaro. V. Lhiauhet-Vallet. M. R. lesce. L. Pre % itcra. M. A. Miranda, 
(lie,,,. Re. iu.\icol. 2009. 22. 17;. 
195. G. Viola. 1'. (irohc;lnv. \1..•\. Linardi.:A. Salvador. (. Basso. J. Micicarck.S. 
D. Acqua. 1). Vcdalcii. F. Da!FAcU/na. To.\ic c,l Sc•i, 2010, 118. 236. 
I96. F Vargas, . ('arsuclas. M. A. NIirancla. F. Boscar, /-'hc,loclrent.plrk,/,iol, 
1993. 58. 471. 
197. B. HevTnc. S. Kohnen. D. lirault.A.Nlouith\s-Mickalaci, F. I libel, P. flans. N-1. 
I. Auparl. NI. Iluebeke. Phctochenl. Pholnhiol. Sci., 2003. 2, 939. 
198. P. J. Bilski. M. A. \'ulak. V. Zhang. D. E. Moore. C. F. C'higncll, P/:otochenn. 
I'hc,tohic,l. 2009. 85. 1 327.  
199. F. Vargas. C. Rivas. A. Fuentes. A. T. C'heng. G. VClutlnl, J. I'ltutocchcr►i. 
/'hutwMol. ,1-Chr'in, 20(12. 153. 237. 
xv 
200.P. Bosca. M. C. Cuquerella, M. L. Marin, M. A. Ni randa, Nirnrnclrcu, 
Phuwohrol.. 2001. 73.463. 
201 _ N. Canudas. C. Contreras. Phampazie. 2002, 57, 405. 
202. R. Arce. C. Garcia. R. Oyola. L. Pinero, I. Nieves. N. Cruz. , J. Photochem. 
Pirutohtnl. A-Chen, 2003, 154, 245. 
Chapter 2 
Photochemical Studies on 
Photosensitizing Drugs Prulifloxacin and 
80 
Cef tizoxime 
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Introduction 
Recently. much attention has turned to the problem of biological photosensitization by 
drugs. Indeed, despite their excellent therapeutic activity, many drugs can induce 
phototoxic. photoallergic and photomutagenic phenomena, strictly related to the drug 
photoclienical reactivity '-3. photosensitization reactions leading to phototoxicity are 
generally considered as belonging to either the type I (radical mediated) or type II 
(singlet oxygen mediated) 
There are photosensitizing drugs of varied structural variety and significant variations 
in the phototoxic mechanisms must be expected depending on the difference in 
structural features'_ Moreover, associated with its own chromophoric structural 
features, it is the individuality of the drug to follow a typical course of 
photodegrmdation and photosensitization. It is therefore highly desirable to study the 
photochemical reaction of each individual photosensitizing drug. 
Oxygen is an abundant element with multiple faces. Its most common and important 
one is the molecular form (Q_). which is a prerequisite lbr all aerobic cell 
metabolisms. Singlet oxygen ( 1 02) is an excited state of molecular oxygen and can be 
produced by energy transfer (type I1 reaction) from excited triplet photoscnsitizers 
such as llavins. tetrapyrrols, protoporphyruis, rose bengal, benzophenone and 
riboflavin to the molecular oxygen. Several drugs are known act themselves as 
potential singlet oxygen sensitizers. Singlet oxygen is very toxic to organisms because 
it reacts with important biological molecules such us unsaturated lipids, oxidizable 
amino acids. and nucleic acids. particularly guanosine derivatives "_ The resulting 
reactions cause destruction of membranes, enzyme inactivation, and imitations, all of 
g 
which can Lead to cell death. Singlet molecular oxygen involving photochemical 
reactions are a matter of current interest, mainly due their important rolc in the 
photosensitization processes and drug phototoxicity °. 
So the studies on singlet oxygen mediated pholorenctions of drug are relevant to 
understand the mechanism of drug phototoxicity. With this interest herein we have 
undertaken the following study: 
Al Oxidative Photodegradation of Prulifloxacin under Aerobic Condition 
FBI Singlet Oxygen Mediated Photooxidabon of Ceftizoxime, an Antibiotic drug 
Section [A] 
Oxidative Photodegradation of 
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Prulifloxacin under Aerobic Condition 
S4 
Oxidative I'hutodegraclatiO►n of I'rulitlo\acin uncicr .\cruhic Condition 
I:luon►cluirl(dunes are al I'dati\cly new class u , s\IithetIC antihiutics \\itl► potent 
bactericidal 	~', broad spectrum activity against rllanv clinicalltt important lalpou,ks 
which arc responsible fir \ ai iet\ ( t intectiOn including Iii] nary tract infections 
((. I'l). ,_a~trointestlnal infections. reshiratory tract infections (R i I). sexual I\ 
transmitted diseases IS 1 I)) and skin intirctiuns. They are primarily used against 
urinar' tract intec iii and are a'so clilnicalk useti►1 against hrestatitis. infections of 
skin and bones and penicillin resistant se's ually transmitted disease. These agents are 
also employed against bacterial enteric infections. prophylaxis in the immune 
ccnlhruiiiiset neinyobenie host. NC (lUiflclofles prce•irlc a valid alternative 
antibacterial therapy, especially in areas where the prevalence of penicillin resistant 
and nlacrolide resistant c►rianisnls exists. f heiir eliicacy. -good hharlllaco►kinetic 
properties. and tolerability have made them l useful worldwide 14 . tluorc►clu11101 ►Iles are 
also widely used in \ eterirlary medicine t ' but these drugs are well known to exhibit 
phototoxic. photonluta`eenie and photocarcinogenic properties '`' 
Prullfloxacin (PI.F, 1) is a no cl an orally active Ilurccluiinolonc antibacterial drug. 
!PrcMloxacifl contain, ,l cquinolone skeleton 	ith a tour-member rill, in the 1. 
position following oral administration, the drug is metabolized by esterases to 
ulitloxacin. It shows its antibacterial actl\ - Ih' by inhibiting DNA tiyrase• thus 
preventing IDNA replication and s\ntlicsi> ' 	. It is mainly used in the tl'eatnlnt of 
bronchitis exacerbation and lover urinUt \ tract infection. community-acquired 
respirator, tract infections as well as gastroenteritis including infectious diarrhea 
The most tregeiierit cI(I\ er;e reactions obscr% eel in clinical trials \\.ere `gastric pain. 
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nausea and skin rash '`. Despite its usefu] clinical activity it is also known to posses 
phulotosmsiozlng properties that lead to phoiotoxie responses in both horn .n and 
animal subjects ". In continuation of our interest in the photochemical reactions 
involved in the phototoxicity of the photoscusitizing drugs and their mechanisms and 
to delineate the nu(lerlyino photochemical reaction that may possibly he involved in 
its phototoxicity, herein we have examined the photo behaviour of the antibacterial 
drug prulifloxacin (PLF. 1) under aerobic condition, as the photochemical behavior of 
photosensitizing drugs under aerobic condition is particularly relevant to understand 
the Cu rtro photobiolomical effects'r.Photolysis of PLF (1) in the presence of oxygen 
resulted in the formation of one photooxidation product, identified as (2) frum its 
spectral (LR. 'H NMR. C NMR, Mass spectra) properties (Scheme-2A. 1). Formation 
of the photodegradation product (2) was rationalized as initial photosensitized 
generation of singlet oxygen ('02) by the type II photodvnamic action of the drug and; 
subsequent quenching of the generated singlet oxygen by the drug. 
Fxperitnental 
C/inn lea Is 
All chemicals used were of analytical grade. Pure prulifloxacin, methylene blue rose 
bengal, riboflavin, benzophenone, sodium azide were purchased from Sigma Aldrich 
(India). 
~I pparatus 
Irradiation was carried out in a Rayonet photochemical reactor (The Southern New 
England Ultraviolet Co_ Model IIPR-208 equipped with four RLL-351) um 
fluorescence lamps). IR spectra were recorded ac KBr discs on a Perkin Elmer model 
spectrum RXI. IH-NMR and 'C-NMR Spectra were recorded on a Broker Avance 
8(► 
[)R\ -3U( Spectrometer usin, I .`1s as internal standard and ( 11)('13 as solvent. High 
resolution Mass Spectra \\crc determined with a \ (_~-LA13-1HkQ9 spectrometer at 70 c 
V i niration ' olta`ve. \icrek silica uel 60 F,:, plates were used f or analytical thin 
la\er cIuvnlatoraphy ( 11.( ): C olunitl chromatography was perfOrnlecl on \lerck 
silica !cl 60 (6()-12O mesh). 
I'/t utnirracliatinil Frc,eeclNc' 
A solution Of P11 (I) ( I5Omg, 0.3; nitil) in phosphate butter under aerobic 
condition was irradiated tier (► hr in a Ravonet photochemical reactor (l he Southern 
New England l Itraviolct Co: Model RPR-208 equipped \\ ith tour RI. I I.- 5O nil) 
fluorescence lamps) for the complete conversion of reactants. I'nr4tress of the reaction 
was monitored by thin layer chromatography (cl1ll1rl)tOr1ll: methanol , 7:3). At the end 
of the reaction torinatic►n of one major photc►hroiluet was indicated on TI .C. x\ Inch 
\V 1S i OIated and p1111 tied by col 	chronuito►grapll\ using dichlc►rc►1»ctllane: 
methanol (8:2) oil a silica'-'Cl Column. I he photo product was identified as 6--iluorc► - 
I nlethvl -4- oxo-7- [piperaiin -1- 'J ] 1.4-ciihycirc►-[ 1,31  thiazeto[3?-a]cluinolitle- 3- 
carboxylic acid (2) from its fi llowing spectral properties: 
6-flnuru-l-inet/n'1--/-nxn---(hilrc ,1'a, ir1-1 .t ,1j-1,4-clip ,drOf 1,3jthiaZc'tu(3,2a/quiiioline- 
3-turbo v is acid (2): 
Yield: 55.5 In`, (37°o) : IIR\IS : calcc[ for (\1 ) C ie,[ - I IrJ N O;S, 349.3$1: tOun0. 
34 9).3-~): IR (KRRr): :40(1. 1605. 1-19" cn :'ll N\IR (CDC'1 O. ppm): 2.O (:.l I1.NlI). 
13.() (s.111,011) .7.96 (dill. .1 I 	.5-I I). 6.40(d. III. J 7. 8-H). 6.06 (cl. I I I..I- 7. I- 
11). 3.58-3.88 (111.-Ill. pipera/ine), 3.88-4. 18 (nl.411. piperarim)e), 2.20 (d.3 II. J 7. 
('I [ : ) : 'C N `Ill ( CDC). ppm): 177.5. 171.5. 159.5. 1 52.6. 143.9. 140.6, 108.5. 
5_'.1.45.6: MS. Ili is 341) \[ 1. [ \l-I L 2 I..:'_c►. 
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.Sill /et O.1 v en d('tection 
In order tt , LOntirlll the role of •inh!Iet u.X\_Cn U, ill Oxiddti\C phutudegrad tion 0t 
PI.l= (1) hhotolvsis %\ as }performed in the presence Of sodium .►ride ( NaN ;) which is 
WormJII\ used as a trap for sim_Zet oxygen t 1 O,) "'. Similar experiment was earned 
out by using ditterent sensitiiers such as methylene blue. rose bengal. riboflavin. 
benzophenone to studs' the effect of triplet energy of sensitizer can the percentage 
yields cif product. 
Results and discussion 
I he formation of one nmjor hhotoproduct . 6-tluoro- I -methyl-4-oxo-7-I hiherazin- I - 
vi] -1.4-dihvdro-( I.31 thiazeto [3 2-aJ cluinolinc-3-carboxylie acid (2) which was 
obtained On irradiation of phosphate butler solution ot prulitloxacin (1) under aerobic 
condition is depicted in 'Cllcrnc -A. I . The spectral features correlated to the assigned 
structure of the pn)duc:t and were clone in COIllpari.son with the spectra of the starting 
drug. The ► I-I-NMR spectrum of the hhotoprocluc:t (2) showed signals similar to those 
of }prulitloxacin, except for two signals at O 3.03 and 1.98 ppm for the 4-('I I, and 5-
CU groups associated with substituted 1. -dioxo(-2-one moiety of starting drung, 
broHtIoxacin. A new signal in the product (2) at 2.0 hhm was assigned to the proton 
of N11. The ' C-Nh-1R spectrum of hhotoproduct (2) showed signals similar to those of 
pridifioxaein except for the loss of signals for substituted 1, 3-dioxol-2-one moiety. 
The result indicates that this hhctemeoduct is formed by irreversible trapping of self-
photogenurated singlet molecular oxygen. The tl~l'lllatii►n of hhotoprc+duct through 
oxygenation is relevant to JJi'Idei'Stand the mechanism of photo biological et'R ct of 
PI.F (I). The oxidative photo  degradation pathways of PI.F is shown in scheme ?A.? 
M 
Irradiation of Fl ,F gave triplet excited state of drug (3PLF) which generates singlet 
oxygen ( 1 Q) through energy transfer to molecular oxygen. Reaction of this active 
species with PLY ground state produced PLF and O>_'-  .There are sufficient examples 
in the literature on the reaction of singlet oxygen (0-) with aliphatic amines'"'9(as 
the piperazinyl nug of PLF); the reported result is the t;enerat ion of an amine nidical 
cation and superoxide anion (0' )- Subsequently reaction of these intermediates 
form an iminiun cation 3O. which may be hydrolyzed to give photoproduct (2). 2- 
oxopsopanal and carbon dioxide. Oxidative photodegradation ofPLF (1) to give (2) is 
in agreement with this mechanism. When PLF (1) was irradiated with singlet oxygen 
scavenger sodium azide {NaN-,). It competes with drug for singlet oxygen ('Q), and 
decreased the availability of singlet oxygen ( 1 0-,) therefore slowed down the rate of 
photodegradation. 
In order to further ascertain the oxidative photodegradation of PLC (1) by its 
quenching of the serf-generated singlet oxygen. the drug was photolysed under the 
same experimental condition, in the presenc3 of well known photosensitized singlet 
oxygen generator, where same photoproduct was obtained in different yields. Rose 
bcugal and methylene blue was much more efficient than riboflavin and 
benzophenone in the photosensitized decomposition of PLF (1) Table 2A. 1. This may 
be due to the face that rose Bengal and methylene blue, with lower triplet energies, 
produce singlet oxygen in large m uountIt" by type 11 mechanism''. On other hand 
ribotlavin and benzophenone (higher triplet energies) act mainly by type I 
photosensitized pltotooxidation. do not produce significant amount of'O,'`'. 
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Sensitizers Triplet eneray(k cal /mole) Yields N) 
Methvlenebluc 35-5-34.0 36.4 
Rose Bengal 
Riboflavin 
39.2 -42.2 
57.S 
35.0 
34.9 
Benzophenone 68.6-69.I 	 33.6 
Table 2A.1 Effect ofTripiet energies of different sensitizers on the yields of product. 
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The oxidative photodegradalion of PLY (1) to produced (2) is relevant to understand 
the mechanism n of nxygcn-dependent rhotobiologica1 effect of drugs and also give 
knowledge that one can alter the rate and direction of biochemical reactions of drug 
by using both singlet oxygen (102) generators and singlet oxygen ( 1 02) quenchers. 
Section [BI 
Singlet Oxygen Mediated Piotooxidation 
93 
of Ceftizoxime, an Antibiotic Drug 
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~Ifl Sin!tict O\';en Mediated I'hOt(►t)\Xlatiun of(cftiio\inle. an Antibiotic Drug 
Ox n e; are known i„r their pharmacological properties such as antibacterial. 
an! ituhercular. arltilehral. antiviral and antinialarials ". Indeed. despite their excellent 
hha n~ace~le,ic•al application the Iiterature report have shown that intensi' e use of 
oximes as ciru2s intake of these chemicals ti,Ilowed by enzymatic 0XIdatiun ma~ 
result in the formation of a variety eat* reactive interlllcdiates which may lead to cell 
and tissue tIanlatPe in hiolo"Ical ur`uanisnl 	. In addition to this some of their 
dcri'ed drugs are known to eNert hhototcxicith as a significant side effect ". which 
introduces a serious limitation to their u-,c in therapy. t he mechanisms that trigger the 
phototoxic response to such drugs are unknown and one prerequisite for a deeper 
understanding is the exact knowledge of the hhotoehenni`try of these drugs. 
Cettizoxime (CF 1. 3) a cephalosporin for pareliteral use possessing an aminotlliazole-
oxinle nloi.et\. exhibits a broad spectrum of actin It\ against Gram-positive and Gram-
neg:ati\ e bacteria. It is particularly active against enterohacteriaceae (including beta-
lae'taItlase-positive strains), and is resistant to h\drolysis by beta-laetamases 11' 4, 
Cettizoxime (3) has limited activity against pseudoIhno11as aerUgnosa. and thus Cannot 
hL reco nmended as sole treatment of known or suspected non-urinary tract 
Pseudomonal inti:ctions. Similarly, although t1a'ourahle clinical results have been 
obtained in patients treated \,, ith ecftiioxinle for infection., caused by IIiIxC 1 aerobic. 
anaerobic organisms (such as intra-abdominal. and obstetric; and gvnaecological 
infections), the relatively low In vitro activity of eethloxune (in common with most 
other third generation eephalosporins) against haetemicles yrasgilis and entemeocei 
may restrict its usage in situations v here these organisms are the suspected Or pro\ en 
hatlh en--. (efiitoxiinc (3) appear. tt , be '.imilar in cllicac% to several c►tller 
":CpIIuIo,llk 11111-, 111 	c1 IL )I1:ll(\ trait IllteLII~)I1 	III c:l(ICrl\ and or dcb111tated 
patients, and in chronic and or cOIllI)Iicate(f urinar\' tract inti:ctions. ('ctti/oxime (3) is 
also c1Tccti\c clinical l\ and hactcriulo`ulcally ill skill, suit tissue, bone and joint 
infect ioii. septicaemia bactcracnlia. meningitis and neonatal Intuct ions. Single 
intramuscular (lases of cettiiuxinle appear similar in efficacy to aqueous procaine 
penicillin G Illonon'locac Niue to nunhcllicillillase pruduciilg ncIssc:ria gonorrhea. 
('ettizoxime is also highly d-tctti\c against hcnicillinase-producing strains. 
('cttiioxime (3) is u;ctul in the treatment ot'gonorrhoea in places where pcnicillinase-
tprodlucinyI strains are common. I his agent is not metabolized and has a longer halt= 
life( 1.) hr) 11.44. Despite clinical utility the most common adverse effects of this drug 
have been reported such as hvperscnsiti\ it\ reactions including skin rashes, urticaria 
uosinuphilia. fever. haemul tic anaemia. eruption. nausea. anorexia, diarrhoea, 
headache, numbness. dvspIIo a '1z, . Ill shits of this it is also demonstrated valuable 
toxicit 4 as well as phututuxicityy 	Due to our interest in tilt drug phutochemistry 
and phototoxicity III the present work we have investigated the photochemical 
behavior of CFF (3) in the presence of'. methylene blue as a photosensitikr under 
atrubic condition for a correlation to its phototoxic mechanism as clot sensitized 
formation of singlet oxygen and it's reaction with bring are relevant to understand the 
phutotuxicity of drug . Irradiation of RlttllaiilIlc solution of ('Fl (3) in the presence 
of in th\ Ienc blue under aerobic condition resulted in the formation of one major 
photoo\idatIoil product (Scheme-2E3.1 ). \\11iL•h was identified a (4 ) from its spectral 
pruherti '\: (lot. I li-\\1R. '('-\\1R. and \lass spectra). The formation of the 
photoproduct (4) was explained through photosensitized :generation of singlet 
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molecular oxygen through type-II photodynantic action and its reaction with drug 
(Scheme-2B?), 
Experimental 
Chemicals 
Al] chemicals used were of analytical grade Pure cetiiznxime- methylene blue. rose 
bengal, riboflavin, bencophenone, Sodium aside, Sodium was obtained From Sigma 
Aldrich (India). 
Apparatus 
Irradiation was carried out in photochemical reactor equipped with medium pressure 
mercury vapor lamp inserted in water cooled immersion well with continuous supply 
of water. IR spectra were recorded as KBr disc on a Perkin Elmer model spectrum 
RXI. 'H-N.M.R and "C-N.M.R Spectra were recorded on a Broker Avance DRX - 
300 Spectrometer using TMS as internal standard and CDCI, as solvent. High 
resolution mass spectra were determined with a VG-ZAB-BEQ9 spectrometer at 70 
cV ionization voltage. Merck silica gel 60 F,tit plates were used for analytical thin 
layer chromatography (TLC), column chromatography was performed on Men:k silica 
gel 60 (60-120mesh). 
Photoirradiarion procedure 
A solution of CPT (3) (500 mg, 1.23 mM) in methanol (150 ml) in the presence of 
methylene blue under aerobic condition was irradiated in a photochemical reactor 
equipped with medium pressure mercury vapor lamp insetted in water cooled 
immersion well with continuous supply of water for about 5 Ii ours at room 
temperature. The solution was continuously stirred during photolysis. Progress of 
reaction was monitored by TLC cho lorotbnn: methanol (7:3). ARet 5 hr of 
97 
irradiation, removal of solvent in a rotatory evaporator and silica gel column 
chromatography dichlonomethane: methanol (S:2) of photolysate gave photoproducl 
(4) which exhibited the following spectral properties: 
(6R. 7R) —7- f(Z)-2 — (2- nminotbicrcnle- 4- r1J-2- (oxo- aeetl ,laminol- 8- own- 5- 
thin- azubirvc/u [4.2.0/ ocl- 2- erne-2-carboxylic acid {d): 
Yield: 220 mg (44%) HRMS: culed fur (VI) C13H13N4O5Sz, 354.36116; found, 
354.3614; IR (KBr): 3448, 3250, 2935 ,2852,1740, 1725,1622,1536. cm-t ; 1 H—NMR 
(CDC1; 6. ppm): 12.0 (s, I H,COOH). MOO ((1.1 H, r—R. l Hz, H CON H). 6.55 (m, I H,H- 
3), 6.35 (m,.2H, H-4 of aminothiozole moiety)565 (dd,1 H.H-7), S1) (d, I H,J= 4.6. H- 
6). 4.6 (s, 1H,NHr); 13C-NMR (CDCI; o, ppm) 173 2-168 (C-4& C-5 of aminothiazolc 
ring). 164.2 (C-8). 163 (COON),160.2 (CO). 140 (C-2 of arninothiazole ring),59.8 (C- 
7). 126 (C-2). 123 (C-3). 57.8 (C-6)-24.6 ((1-4): MS: m%z 554 [M4] 353 [M'-1] . 306 
[NI—COON]. 
The above photoreaction was carried out in the presence of singlet oxygen scavenger. 
sodium azide (NaN3) for establishing the involvement of singlet oxygen in this 
photoreaction. To observe the effect of triplet energies of various sensitizers, the 
photolysis of (FT (3) was also carried out in presence of different sensitizer by 
keeping all factors identical. 
~ x 4N~ COON HZN 
OCH3 0 
Ceftizoxime (3) 
IIN 
sen 
(Methylene blue) 
02 
S 
S \ O 
N COOH 
H,N 	N 	N 
O H 
O 
(4) 
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Scheme-2B.1 
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Results and discussion 
The one major pho to oxidation pho toproduct (4) was obtained on irradiation of air 
saturated methenolic solution of cefjzoxime (CFT, 3) in the the presence of 
methylene blue as it photo senstizer in a photochcm iud reactor equipped with median 
pressure mercury vapor lamp (Scheme-2B. I) The spectral features correlated to the 
assigned structure of the product and were done in comparison with the spectra of the 
starting drug. The ' H N VIR spectrum of photoproduct (4) was devoid of a signal at b 
4.01 ppm for methoxv-i in no group dint was present in the starting drug ccRrzoxime, 
however rest of the proton signals were similar to that of the parent drug. The I "C - 
NMR spectrum of photoproduct (4) further supported the loss of the methoxyimino 
group. A new sigmI at (3 160 ppm corresponding to keto group indicated that the 
methoxynnino group has been replaced by keto group in the product. I'he mechanists 
of fortnation of photoproduct can be rationalized as interaction between oxygen and 
the triplet state of sensitizer (methylene blue) results in energy transfer yielding 
singlet oxygen ('O,). The generated singlet oxygen ('O2) would undergo [2 i 2] 
cycloaddition with the C' =N double bond of the CFT (3) to gave dioxetane analogues 
as in the case of the cycloaddition with olefins 'SO. I he initially formed dioxetane 
then decompose results in the turmation of photoxidation product (4) by loosing 
nitromcthane. The mechanism outlined in scheme -2B.2. The participation of singlet 
oxygen was confirmed by repealing the reaction in the presence of well kno'~ n singlet 
oxygen quenchers sodium azide (NaN3). The drastic lowering of the yield of products 
in presence of scavenger contirnu that 'O, is active oxidizing species in this 
photureaet ion. In the absence of oxygen the reaction cannot occur is also further 
support the sinvlet ox'gen palicipatios in this uhotoreaction. The effect of triplet 
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Sensitizers 
	I rihlet therg\(L cal mole) 	Yields C' ~ f 
Methylene blue 	 5.5- ;4.0 
	
44 
Rose heii zil 
	
9.2 -42.2 
	
43.1 
Rihotlavin 
----
E3enic►hhcnone - -- --~- ---- 
Table 2R.1 F Tect of triplet encr 	of ditterent sensitizers on the yields of 
Photoproduct 
42.5 
41.3 h8.6-6().1 
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CIICI`'.IL 	t 1 \,IIIR'LI 	CII 	/L'l 	1II1 1 IL- I)l.'ILCIItJ L \i llk 01 I)I7ot( I)1O(IUL't ll;l , tit) been 
studied. It ww,Is . hser%e(1 that ruse hc:n~1-al Mid m eth Ienne blue was much more etlicient 
than o}Ht1gy1N In and heIIz(opIiemit,ne in the })Iiutosensitiied (lec0i'itosifi(,n OI (l 1 (3) 
(I ,IbIc-,li. I t. I-hiN ma \ he (lue to the tact that methylene blue and rose heml2al With 
to\ver trilAo l illr`±ie- pir(xiuee singlet ox'v .&e n in I,irge 	iiit uint 	-. hti tole f 1 
mcchanisni 	 . On other hand rihutla% in and hetv.op)lien(une (higher triplet eliergies) 
act mainly by type I photosensitized J)ll(t(oXiclatioil. (10 not (Produce significant 
amount  
In conclusion, the present study has demonstrated that the photooxidation products are 
formed h singlet oxygen ( I 0,) mediated plxotocymiami(: action upon sensitized 'ffsihle 
litht irradiation of eettiiuxime (3). (oR. 7R) 7_ i(7.)-2 	(2- atninotliiaiole- 4- vl)-2- 
(oxoi- acct\ lamina j- `- tsxg- 5- ilia- azahicvclo 14.2.O j act- 2- e e-2-carhoxvlIc acid 
(4) was identified 1, the mails pliotl),)xldation product. ] he investigation of 
photochennical properties of ('ettIZOXIIime used in clinical medicines is of great 
relevance from photoblological as \\ ell as 1butonneclicaI point of \ iew since singlet 
oxygen f ormation ensuing photooxidation of the drug an(1 hi(mu,lecules is one of the 
main routes tier the drug hlwtot(►xicit\. 'I he present findings may have an implication 
to the hhotutoxic; effect of the ((rug. 
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Chapter 3 
Photochemical transformation of 
Photosensitizing Drug Clopamide and 
107 
Difloxacin 
I It oduction 
I►..• d;rte~l intcrc•st Of Illlotocllt'llll~N in the prt~perties t't , the clectronicaIII excited 
.talc. Of cOnipOuncl, Ot pharmaceutical use Iias been rapidly inereastng during the last 
decade ,. 'I his has been motivated by photohiolugical reasons, connected to the 
increa in!e nu►llher of ewes Of clru2 induced plilic1sen:itiZatic1n disorders such as 
photonluta~~enic. photocarciao (genic. photoallerg ' and phototoxicicftye 	. The 
generation cif an adverse photosensitivity response can be postulated to involve one or 
more of the pathways namely singlet oxygen formation, an electron or hydrogen 
transfer could lead to the tonnation oh tree-radical species. a covalent photohinding to 
hiontolecules and photoproduct in decomposition reaction 	In general it Immerge 
from this picture that phototoxicity is strictly related to Photoreactivity N . As the 
number and \ ariety of phototoxic compounds is large so emphasis should he given on 
those photosensitizing drug, whose molecular mechanism of phutosensitizatian is still 
u►rl:no\ n. 
1h(to}ylduceU electron transfer reactions in drums receiving considerable atZentim in 
recent years from a more fundamental photochemical standpoint and many reactions 
such as cycloadditions. cyclurcversiuns. oxygenation~ anct pliotodegradation cal drubs 
have been documented ►. Photoinduced electron-transk2r reaction is one of the most 
elementary chemical processes and plays important roles in many photosensitization 
phenonmena' ►. 1photoinduccd electron transtirr ( PET) process can be describe as 
electrons are not hound equally strongly in all atoms and molecules. Some have 
~ureatcr affinity fir the electron than others. Electron rich systems which can readily 
e up an electron are called Donor. (I)). ('orresponciin<g1%. electron deficient units 
lnx 
hil► I;,i.L tl 	hilit\ ?'' ;rick up an electron at.c retkrrccl to is :\cccI)tOrs (A). 	13t 
109 
absorption of light of suitable wavelength_ molecules (especially those containing 
c hromophoric groups) can be induced to undergo transition from the ground to the 
excited electronic state. Molecules in the excited electronic state arc generally very 
reactive. They are capable of giving up (or taking In) an electron if efficient acceptor 
or donor units are available in the neigbbourhoodtr Thus, it is worthy to stress that 
studies performed on drugs hearing either simple or complex chromophoric group. 
The study of photochemistry of these drugs will make remarkable contributions to the 
broad area of the molecular mechanisms of drug photosensitization which might be 
relevance to understand the in vivo photobiological effects and help to prevent the 
undesirable side effects of photosensitizing drugs before it introduces in clinical 
therapy or products made available in the market_ With this interest herein we have 
investigated the photochemical behavior of ciopamide and difloxacin under dilTerent 
reaction conditions. 
IAI Photoinduced Electron Transfer Fragmentation of Clopamide, a Phototoxic 
Diuretic Drug 
CBI Photedecomposition of Photosensitizing Drug Dilloxacin 
Section A 
Photoinduced Electron Transfer 
Fragmentation of Clopamide, a 
Phototoxic Diuretic Drug 
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JAI Photoinducer Electron Transfer Fragmentation of Clupamide, a Phototoxic 
Diuretic Drug 
Diuretics are a wide class of drugs eliciting an increased production of urine by 
increasing the urine flow rate . diuretic usage leads lo increased excretion of 
electrolytes especially sodium and chloride inns and water from body without 
affecting protein and vitamin, glucose ,amino acid reabsorption. Diuretics are used in 
treatment of different edematous conditions, resulting from a variety of causes 
(congestive heart lailurc ,ncpluolie syndrome, and chronic liver disease) and in 
management hypertension also is used as adjunctive therapy in the treatment of a 
wide range of clinical conditions, including hypercalcemia, acute mountain sickness, 
glaucoma and primary hvperaldoslerism °-''.There are several classes of diuretic 
drugs are known such as Thiazides (e.g_ henzthiazide), loop diuretics (c.g., 
bumetanide), potassium sparing diuretics (c.g., amiloride), carbonic anhydrase 
inhibitors (e.g., acetazolamide), osmotic diuretics (e.g., mannitol) and mercurial 
diureticse. ( g., mersal yl) .Among them some were reported to exhibit the phutotoxic 
effect "as an adverse side effect. 
Clopamide (CPD,I) is an oral diuretic agent 	"' that shares the same aromatic 
sulfonamide base as the thiazide diuretics but is without the double-ring structure 
characteristic of these compounds'(,. It has similar properties to thiazide class diuretics 
which act on the inhibiting reabsorption of sodium in the proximal renal tubule and 
stimulating chloride excretion, resulting in increasing excretion of wale'' .". 
Clopamide (1) are being more widely used for the treatment of hypertension & 
excessive fluid retention as in cardiac failure_ cirrhosis, chronic renal laiIare. 
Nephrotic syndrome, coshing s disease '3. Previous studies have shown that a fixed 
112 
drug combination ut pindulot I  mg. clopanritic 5 ntg and endralazine I  mg once 
daily could control blood pressure in about 90% of patients suffering from moderate-
10-severe hypertension - It has also hcen reported that the use of a betablocker with 
intrinsic sympathetic activity (pindolol) in association with a rhiazide diuretic 
clopamide seems to induce a ravourahle change in systemic resistance without a 
deleterious change in cardiac output 2: . Cloparnide has many adverse side effects such 
as dizziness, nausea, tiredness and headache electrolyte imbalance, hyperglycaemia, 
gout, dry mouth, thirst, weakness, muscle pain and cramp, seizures, hypotension, GI 
disturbances, anorexia. sialadenitis. headache, impotence, yellow vision, 
hypersensitivity reactions 7's. Besides these effect clopamide (1) has also been reported 
to show phototoxic as an adverse side effect '/. This has stimulated to study the 
photochemical behavior of it with the aim to establish the target for the phototoxic 
effect and the chemical reactions oeculTiug. In continuation of our research interest in 
the present study, we have, here investigated the photochemical behavior of CPU (1) 
in the presence of electron doper, N.N- Dimethylani line (DMA) and electron 
acceptor, 1,4-Dicyronaphthalene (DCN) in UV-light under anerobic condition with 
the aim of isolation. identification of its photoproducts and elucidation of molecular 
mechanism. The present study may have significance in rationalized the observed 
phototoxitity of this drug. Irradiation of methanolic solution of CP1) (1) in the 
presence of electron donor DMA under anerobic condition results in the formation of 
one major pIwtoproJuct (21- When it was irradiated in the presence of electron 
acceptor DCN under the same condition a different photoproduct (3) was obtained. 
Which were isolated and identified from their spectral (IR. H-NMR,''C-NMR, and 
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Mass spectra) properties (Scheme-3A_l). Formation of the photoproduct (2) and (3) 
was explained by photoincuced electron transfer mechanism. 
Experimental 
Chemicals 
All chemicals used were of analytical grade. Pure elopamide. N,N-dimethylaniline 
(DMA ) and 1.4- dicyanonaphlhalene (DCN) was obtained from Sigma Aldrich 
(India). 
Apparatus 
Irradiation were carried out in photochemical reactor equipped with medium pressure 
mercury vapor lamp (Philips, 450 W) inserted in water cooled immersion well with 
continuous supply of water. IR spectra were recorded as KBr discs on a Perkin Elmer 
model spectrum RXI. H-N.M.R and ~ 3C-N.M.R Spectra were recorded on a Broker 
Avance DRX -300 Spectrometer using "CMS as internal standard and CDCI3 as 
solvent. High resolution mass spectra were determined with a VG-ZAB-B£Q9 
spectrometer at 70 e V ionization voltage. Merck silica gel 60 F,54 plates were used 
for analytical thin layer chromatography (TLC), column chromatography was 
performed on Merck silica gel 60 (60-120mesh). 
General Ptoroirrat/in floe procedure 
A solution of elopamide (1) in methanol was stirred for I h before irradiation and was 
kept bubbling during the irradiations. The course of reaction was monitored by thin 
layer chromatography on pre-coated silica gel TLC plates using chloroform- acetone 
(9:1) mixture. After the completion of reaction (when desired conversions have 
reached) the solvent was removed in a rotary evaporator and products were purified 
by silica gel column chromatography. 
Irradiation of , ('NI) (1) in the presence of electron (loner (1)\1.x) 
('Pt) (I) (5O m it.'.. I.3U iii NI) %%as (lisSOlved in 501) nll ot , methanol and was irradiated 
tier 0 hour in photocltennical reactor in the presence of N.N-dimethylaniline (DMA). 
is kno\u n to act as an electron donor 	under anaerobic condition. After ltH1Oe iW`r the 
steps as described in the general photoirradiation procedure, the photoprocluct (2) was 
obtained which exhibited the following, spectral properties. 
2- choloro- 5- ((2.6-dinrethN 1pipericfin- I-% I) carbanro\ lc) benienesulphonic acid 
(2): 
Yields: 320 m,`, (G4h'„) HR%IS: calert tur (N1) C' 14 I1 1 ,CIN O4S, 346.8297; thund, 
346.82913: IR. (KBr): 3050. 298(), 1734. 1625. 1345 (CONH), 1344 (SO,H) cm- ': 'H-- 
N\1R (C'DC'l:.c~ ppm): 8.54 (s.1 11.1l-6).8.O (s.l 1I.NH). 7.8 (d.I H..H-4). 7.72 ((1.1 H.H-
3). 2.9 (m. 21-1. 1-1-2' and 11-6). 1.55 (m. 211. H-3') 1.10 (rn,6H,two C'H;group of 
pipendin nioietv), I ,C-N\I IZ (C'DC'I ; . ppm): 164.9 (C'O). 144 (C- I ). 135.7(C-2), 
133.6 (C-5). 132.7 (C-4),l 0.3 (C-3).122.6 (('-6). 50.9) (C-?'and C-6'). 31.4 (C-3'and 
C-5' ). 16.5 (two methyl ('1-l; group of piperidin moiety). 20(C-3): 3' MS: mir 346 1 M 
Irradiation of CPD (1) in the presence of electron acceptor (DCN) 
A solution of ('PD (1) (500 mb, I.30 mM) in methanol (500 ml) in the presence of 
1.4- dicyanonapllthalene (D('\) acts an excellent electron acceptor 2 under anerobic 
condition was irradiated tier 5 hours at room temperature. After following the steps as  
described in the general photoirradiaion procedure. the photoproduct (3) was obtained 
which exhibited the following spectral properties. 
1I4 
4- 1I\(Iroxv-\-(2.6-dimcth%le-I-piperid le)-3- sulphan v1-heniamide (3): 
Yield.: 31)1 inc (6(1"'). IIR\IS: calcd for (NI) (`i .i H=iti;OaS.3?7.3t))?:found. 
327.3~)S'):1R(1`13r): 	3060. 	2)75. 	I%l(1. 	1655-I64 	(NH-). I 3 12. 	II65(S0 ) 
l 345(( O\lI) ens : I II--NN.1R ((- l)('I; ci ppm): S.45 (s.111. 11-6). 8.0O (s.1 II. ('ON11). 
7.ti (d.111.11-3), 7.1 9) (d. I 11. 11-2 ). ti.00 (s.1 11.011). 2.9 (m. 2H. H-2'ancl 11-6') 2.0 (s. 
211. NI 1 ,). 1.55 (m. 211. I I-4 ' I.10 (in. 611.twc► (H-, group cat- piperidin moiety ):~ C - 
NMR ((I)('l;& ppm): 164.1) (('O). 155.6 (('-2). 132.1 (C-4). 127.1 (C-5). 121.8 (U-
6). 121.-1 (C-6). 116.3 (C-3). 5O.1) (('-2' and C-6'). 31.4 (C-3' and C-5'). 20.6 (C'-4'). 
16.5 (two ('H; group of pipericli» moiety ): NIS: m i 327 [N1 -]. 
Results and Discussion 
Irradiation of methanolic solution of ('lopamide. (('PD .1) under anaerobic condition 
in the presence of electron donor. N. N-dimethvlaniline (DMA) in a photochemical 
reactor equipped with medium pressure mercury vapor lamp (450W) afforded one 
major photoproduct 2- choloro-5- ((2.6-dimethylpiperidin-I-yl) carhamovle) 
benzencsulphonic acid (2). When it was irradiated with electron acceptor. 1, 4- 
dicvanonaphthalene (DUN) under the same condition the photoproduct (3) was 
obtained is shown in scheme-3A. I . The photoproducts were isolated and Identified
from their spectral (OR. 1 II-N\IR. ~~C-\\1R, and Mass spectra) properties. The 
assignees structures to these products Well correspond to their observed spectral 
pr~perties. The formation of photoproducts has been rationalized through 
photoin(luced intermolecular electron transt' r mechanisms as given in Scheme-3A.2 
and Scheme-3A.3. 
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Cl 
H 
N 
H2NO2S 	 N 
0 
CPD (1) 
hv 	 J hv 
	
DMA DCN 
(electron donor) 	
( electron acceptor) 
Cl 	 ..:: 
H 	 HO. 
HO3S 	
1 N N 
! 	N 
O 	 H2NO2S 	-' N  
0 	- 
(2) 	 (3) 
N 	 CN 
DMA (N,N-dimethylaniline) _ 	 DCN ( 1, 4-dicyanonaphthalene) = i" 
CN 
IIh 
Scheme-3.k.1 
117 
Irradiation of'('PI) (I) in the presence t'electron cloner , N,N dimethvlanitine ( [)M.\) 
under microbic condition Aga\ e the photoproduct _'- choloro- 5- ((16-
di rneth\ 1piperi(lin- l -\ I) carbamoy le) hcniene;uIphonic acid (2). The i1ccIlanisnl tier 
the nDt1iation of photoproduct (2) can he rationalized as irradiation leads to the 
electronic excited state of' eluhannidc (1). Then after an excited ('PD accept an 
electron from electron (loner N,'v cinnctnu1aniIine (I)N'IA) around state molecule to 
ti►rnl corresponding clopamide radical anion ('PD and N_N dimcthvlaniline radical 
cation (I)\I.\' - ). Suh:ccluentl\ the generated clopamide radical anion (('PD) 
un(lerzoes a hydrolysis to \ielcls photoproduct (2) followed by the elimination of 
ammonia molecules. The mechanism outlined in scheme-3A.2 well explains the 
observed reaction. 
When irradiation of clopamide (('P1), I) was performed in the presence of electron 
acceptor 1,-1-dicyanonaphthalene (D('N ). under the same condition, the photoproduct 
4-I 1 vdroxv-N-(?,O-climcthvvle- I -pihericl\vlc)- 3-sulhhamcwl-hetvamicle(3) vas obtained 
A plausible mechanism for the Observed reaction involves a phutoinclucecl inter 
moieeuler electron transfer between the photoexcited clopamide (('PD. I) and 1,4- 
dicvanonaphthalene (D('N) at i'ding the formation of the clopamide radical cation 
('FE)' - and dicvanonaphthalene radical anion (DC'N ). The ,generated ('f'U' `then 
tillo s J substitution 01' the chlorine by the hydroxyl group and a hack electron 
transfer to afThred the corrcapondin1`1 1phuuto 1)1.0cluct (3). The result obtained above is in 
i, oodl a;1recinent With the mechanism depicted In cheme- )A. 3. 
Cl 
H 
H2NO2S 	N N 
0 
by 
Cl 
H 
- 	H2NO2S N  
118 
CPD (1) 
DMA 
Electron Transfer 
Cl.- 
H2N 
Tp 	H 	
+ DMA 
0 	 -- 
+ H20 
-NH3 
	
Cl 	- 
T 
H 
HO3S 	N N 
o 
(2) 
Scheme-3.-.2 
Cl 
H 	 Cl 
by H2NO2S 	 N 
N 
 
O 	 H2NO2S - -' N - 	
DCN 	
0 
CPD (1) 
DCN 
Electron Transfer 
Cl 
H 
N 
DCN + H2NO2S 	N 
0 
+H20 
-HCI 
H 
H2NO?S(NN  
(3) 
Scheiiic-3A.3 
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III c I 1u~itoll. our findinUS -.Ilt,\Vs that clo}paniide (l) undergoes l,hotochemtea l 
tialls h0rnlatloll in the presence of both electron donor (N.\-dimethylaniIille) and 
acceptor 1.-t-cliev.uIt,nxl1hthalcne under anaerobic condition in I. V li~gllt into 2- 
ehuloro- - ((2.(-dilnethvlpiperidin-I-yl) earhalII(Vie) hell/elles1llpIIOI11C acid (2) and 
4- 1 lv droxv- N- (2. 6- dlimethvle- l - piperid le)- -sulphanit,v l-henramide(3) as a 
}lhotohruciucts respectively, through (110101 educed electron transtcr mech anism. The 
results indicate the electron transfer pla> a significant role in elopanpide 
photode,,radation. The in'\ olvenlent of radical ions may account for the hhototoxie 
et-fect~. sometime observed, in therapeutic uses of the drug. Theretore. the clhtained 
data confirmed that adequate light protection should be adopted fir the handling and 
storage of clopamide and suggest that excessive sunlight should he avoided attcr the 
drug, CtIll~llll1}ltloll. 
Section B 
Ph oto decomposition of Photosensitizing 
121 
Drug Difloxacin 
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I 	Vhotodecotnposition of Vhotosensitizing Drug Ditloxacin 
Fluoroquinolone antibacterial agents (FQs) are a croup of potent synthetic antibiotics 
that are widely used iu human and •eterinary meclicinec and have enhanced 
pharmacokinetics properties and potent activity against various parasites, bacteria, 
and mycobacteria, including bacterial strains resistant to other nnlimicrobial agents. 
According to the medical literature, FQs are to be considered the first-line therapy for 
complicated urinary tract infection and diarrhea, considering the bacterial aetiology. 
They are also alternative agents for the treatment of many sexually transmitted 
diseases, as well as osteomyelitis, wound infection and respiratory infections 30-32. 
Although they arc usefull but exert significant phototoxic and skin photosensitizing 
effects upon exposure to UV-A irradiation. which is efficiently absorbed by these 
drugs. Furthermore, some of these drugs appear to increase the inherent 
photogenotoxic and photocarcinogenenic potential of GV light. FQs therefore deserve 
a particular attention in this respect, both because they are widely used and most of 
their known derivatives are phototoxic to some degree "34. Over the past decade, 
many studies have been devoted to understanding exact mechanisms of phototoxic 
reactions induced by FQs. The photochemistry of a series of FQs has been reported ". 
However, The mechanists underlying to the phototoxic effect has not been clarified 
up to now. Thus, it appeared worthwhile to elucidate photochemical behavior of FQs. 
Difloxacin (DIF,4) belongs to a large group of structurally related antibiotics, 
fluoruyuinolones. DIP exhibits a broad-spectrum activity against Gram-positive and - 
negative bacteria "'-aa and mycoplasmas '0. It is proposed that it iwcrleres with 
bacterial DNA metabolisin by inhihi tinui bactcnal topuisomerase- [I (in Giram- 
negative bacteria) and topoisomerase-IV in Gram-positive bacteria, preventing DNA 
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synthesis. and thus disrupts bacterial Cell cluplicatiun4I . Ull= (4) c[iftirrs in particular 
ti-()111 cotller 11uorculuinoluneS on account Of its p tlut>rOpltelt'.I rilDg, at position N- 1 of 
the CainoloWc nucleus, which reportedly gives its enl:1iiecd activity against Gram 
positi\ e bacteria. f Io\V e\ er, in some species it is Ilenletlly'latecl to its primary 
metabolite. saralloxacin (SARA). which also displays potent antibacterial activity and 
in some species DIE (4) is primarily Illetaholii.ec[ by ~~ F 	 pri aril  	 lucuroniclatic>n L '. E3esicie the 
therapeutic use ot this drug it is known to exhibit pliototoxic properties l `. [)ue to the 
presence of two dit'feretlt protonation sites. clltloxacill can present in its zwitterionic. 
catonic and anionic li r111 . 1,1Ch may under.to different photochemistry and can 
correlate to the phototoxic response of this drug. Within this context herein we have 
investigated the photolysis of [CIF (4) at clitterent pH values 7.3, 9.1 and 4.5 under 
anaerobic condition. Irradiation of DIE (4) solution at p117.3. 9.1 and 4.5 leads to 
three plain photuclegraclation products produced via . clecarboxylation process 
opening of the pipraziny-1 ring through c[eprotonation followed by photoinduced 
electron transter and Substitution of a hydroxy group for the fluorine atom, identified 
by IR. 1 11- VIDIR, ''C-NMR and Mass spectral studies as (5), (6) and (7) 
photoprociuets (Scheme:-313.1 ). 
Experimental 
Ch emical.~ 
All chemicals used were of analytical grade. l)itloxaein hydroeholoride was 
purchased from Sigma ('henlical Company (India ).l he purity of drug was checked by 
coulparinyg its melting point. 111-NMR.cu TLC' With the literature values. 
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Apparatrry 
Irradiation was carried out in a Rayonet photochemical reactor (I he Southern New 
England Ultraviolet Cci; Model RPR-208 equipped with four RUL-350 out 
fluorescence lamps). IR spectra werc recorded as KBi discs on a Perkin Elmer model 
spectrum RXI. 'l-NMR and °C-NMR Spectra were recorded on a Bruker Avance — 
DRX -300 Spectrometer using T\IS as internal standard and CD3C13 as solvent. High 
resolution mass spectra were determined with a VG-ZAB-BEQ9 spectrometer at 70 e 
V ionization voltage. Merck silica gel 60 Fisk  plates were used for analytical thin 
layer chromatography (TLC): column chrmnatography was perfortned on Merck 
silica gel 60 (70-230 mesh)_ 
Phato irradiation procedure 
The solution of difloxacin DIP (4) (200mg, 0.46 mM) in phosphate buffer (pH 7.4) 
was irradiated for about 3 hours in a Ravnot photochemical reactor for the wmplete 
decomposition of reactant. Photoreaction were also carried in borate buffer pH 9.1 
and acetate buffer pH 4.5 keeping all experimental condition the same. Similar 
procedure was followed after the completion of reaction (when the desire conversions 
have reached) in all cases. the progress of reaction was monitored by'ILC using the 
solvent system of chloroform: methanol: 7:3  mixtures. The three main photoproducts 
(5), (6) and (7) were indicated on TLC at different pH 7.4, 9,1 and 4,5 values and 
were isolated by eluting with dichloromethane :ethyl ether (11, vlv) on a silica gel 
columns chromatography. The photoproducts (5). (6) and (7) exhibited the following 
spectral properties, 
I 25 
(,-/Irrnr r - !-(l-huurrl'he rrtl)-7-(!-»rrrht lr/,l,rrrr..ia-1-tl) yIllrra1ilr --1(1 /1)-oral (.): 
l irlci: 71) nu.(Th' ): IIR\IS calcd. tier NI 	('1I;, 1',l\:O 355.15, tGun(I 3;>.l(): IR 
(Kt r 1: 355(,.3455. 3009. 30:8, 1744. 1679. 1610. I?(,3. cm 
l{ -\\1{t (()U1: , 6.ppn) 7.91 (&{.{{i. 11-2). 7. 	(d.111.11-5). ().240 	(k{.{11.11-3). 3.06- 
3. I 	(ni.+li.piperarinc). 2?7(s. 311. \'-Cl 1:). 2.4-3.28 (m.311. hihcra/itiu): A% 
\IR(C'fl (l; .6. ppm): I82.O (C-4). I I9.4 (('-2 of 4-phenylc). 146 (('-2). I36 (('-6), 
I ,`) (('-7), {(1S (('-5). 1OS (('-3). 46 (\'-('I{: ). S1 ((', cC U..ofhiperaxinc). 56.5 (C: R 
(':ofpiperazinc) : MS: m'3551 i1' 1. 
6-/1irnro- I-(-1-!lnurnplseisi'!)-7-i/3-(flrmjle_1►selICrI-ainlir()-Ally!- hiet/,rI-a,,unu/-J- 
o (P-I. 4-dihE'dro-qui?:olu:e-3- c•arhoxYlic• acid (6): 
YIcIJ:3O ing (I 5°o): IIR\IS calcd iu,r \I 	('.,1l,,,F,\ 30a 4;1.-13. fund 431.I2 : II( 
(Klir): 3300. (744. 1695. 1679. I61u. 1560•1400cm- ': 'I1-NMR(('D..('I;.o. {rpm): 
ci 
 
II .O(s. I H,COOH), 8.0 Ix. I It. NCI1O)• 7.96 (s. 111.11-2). 7.0) (d. Ill, 11-5). 3.41) (m. 
2!I.CIIC t-t2NCI1 ).3,31Cm,2_N.('H ('(I_NC II ).2.8((s.3F{.HC'ONCH).2.82( .3H.CH 
('H \rC'f{);"C\MR(CD CTh,d,phlt): I78.4 (('-4). 171.8 (C OOH). 102.6 (NC'HO) 
I4,c).7 (('-6). 152.I(C-2), 140.9 (('-t(1). I54(C-3). 117.2 (C-9). 109.6 (('-5). --1 
(('14-C1{,N('H;). 48.9 (CHCHNC'U). 41.1 (C'IIC1INC1H. 37.8 (N'-(H: ) :MS: 
In /433 \1'J. 
1 N-Jlonrap/tc'rtrll-h /tti'rlrv,.va' -7-(-1- i,rc't/1)'Ic' -piperuiirr-1-t'/)-,l-uxn-I.l di/tt'rlru 
r/rrirrhlirre' -3- c•rj-hnxl•lic• acid (7): 
V,cld:28 nt" (14""). I IRMS calcd. for Ni(' , f I.,,I N:Oa 397.40. Ii,unLI 397.25 : IR 
(kI3r): 3625, 341)0. 3089. .31)38, I'44. I7'5. cm : 'f I\\llt (('I):('I:.~i.lilittt):I I.O 
(:.1 I1.C'O(I)I1). 7.91 (s.l 11,11-2). (,.tiO (s.111.1I 5). 5.75 (s.l H,I I-`) 3.0 (ti.lf I.Of I). ?.O(t- 
I f i 1 ni 	411. 	'.i; ink. i. 	' '(: 	I I \ ' (I I ). 7-1-3 'ti (n,. 1I l.liihcraztn~i: 	(\ \1I( 
((I)( l. ci, tlIHti. 	1s 	R4). I 	I . 	(()( )f 1. 	I 	I.~' (('-(,). I - CO. I (( 	'I. 	IY.S t('- 
9),I 17.0 W-10). I I S.4 (C-5).108 (('-3). 3,N.5 (N' (f l ; ). 56.5 (C; & ('; oI• hihetazinc) 
:Sl((' , 	(',g ot pihcra/iile': \MS:►n .. 97 \l 4. 
Results .111(1 discussion 
1~):tlo.xacin I)IF (4) i, an anihhoteric drat ' tlttls the Species present in solution 
dCpend on p11. Bu11cr solutions Of different pH %%ere chosen in order to explore the 
behavior of the different ionic tomns of this substrates. The solution ot'diIloxacin 1)IF 
(4) was irradiated in a Raynot photochemical reactor in phosphate butler pf f 7.3. 
borate huller p} 19.1 and acetate butler till 4.5 under anaerobic condition. Three 
major photoproduct>: (5). (6) and (7) (Scheme -3B. I) -were obtained at e1ilferent pH 
values. which '%.cre isolated and identified by IR. 'II- NMR. ''('-NMR and Mass 
spectral studies. The 'I I-Nl1R spectrum of photoproduct (5) showed signals similar to 
those ot•parent drug di 	except lur the signal at (i 1 1.0 ppm for proton of 
-C'OOH group at position ('-3..'\ new signal at <i 6.2 ppm was assigned to oletinic 
proton. the  C'-\\1R spectrum of hhotobroduct (5) showed snnals similar to those 
of difloxacin. and supported the loss of carhox%l group in the product. by 
disappearance of' signal at d I.66 ppm corresp(Iidtits to carboxyl carbon.. IR spectrum 
of (5) showed absence of absorption hands at 30(1(1 correspoding to the -('OO1I 
group. These observations indicate the loss of -C'0011 group and I I- insertion in place 
of carboxylic group. 
}1-NMR spectrum of hhotoproduct (6) showed signals similar to those 	parent (Iru,! 
floxacil except signals dui• to pipnulLI ring were missing and new signal at 8.() 
n corresponding to the newly generated -Cl 10 group at hihrannyl ring, nitrogen. In 
	
\\1l'. .1,..lrnili ''t e,li ,t pr 	hut (b► ;:II tie sl,'n;il ',t the pil'iraiin\I ring slid not 
:afP'Lir a: tlic 	crt• in time .tqrtmn' tlru . It .II(,%%o•ll t\vOO new siwrsgls at 6 l6. i.6 and ci 
37.8 Ilan corn c;poil(lmU to -('I IO and -( I I: 1oU111, I hese observed data indicated the 
ohenitt,. of pipraiiiiv I rind., occur in hhot(spro(luci too-matil)n. 
In the 1 tI-NMIt pect um. the uutohroduct (7) showed the appearance of new signal 
at 	.() hhm corresponding to the proton ut ( )I I ,group. and the remaining peak for the 
rest of the structure were similar to that ot the parent drug . IR spectrum of (7) 
Showed presence of absorption bands at 362; corresponding to the Off group. These 
observations indicated that the -1= group was replaced by -OH group. 
The plausible mechanism tor the l rmation of photo product (2) at pH 7.3 is 
ratinnnali,.ed as situ to in scheme 313?. Irradiation of DIF (4) under anaerobic 
condition at neutral pH 7.3 relevant to physiological pit (tile drug remains in its 
ittenonic ' fiirrll) ga\ c the triplet c\citcd state of , /. ittcriunic species, which leads 
to it ctccarhoxylation process with the Iiirntation of carhanionic intermediate. the 
protunation of carbaniunic intermediate followed by H- insertion in place of 
carhoxylic group gave the decarhoxylatcd photoproduct (5). ihis seem the more 
reasonable hypothesis, other wise a hemolytic cleavage with formation of tree radicals 
would leads to their stabilization through h\drogen abstraction flow solvent thich is 
thermodynamically ll11ta\'(1l1rC(l process 	 . Free radical may also produce in the 
photodegradation pathway of 1)IF (4) ti'um the transfer of' electron by the triplet 
excited :tats ot'carhanitmic intermediate species to the residual presence ofoxygen. 
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14 'hen irradiation of difloxacin (DIF, 4) under anaerobic condition was performed at 
pH 9.1 (where the drug is present in its anionic lomr) s0 the photoproduct (6) was 
obtained. The mechanism that could account for the formation of photoproduct (6), 
could involve: (a) a fast photoinduced electron transfer between N - and the close 
chi 	that could be favorer) by deproton ation i°''. (h) a subsequent hemolytic 
cleavage of the C-C bond r to the radical cation, followed by an election and 
hydrogen transfer, in accordance with the behavior of several compounds containing 
1-2 etheruntums ``. This process shuuld lead, via the generation of a cnrbene 
intermediata to the formation of an a-aminoalcohol derivative 1, from which 
photoproduct (6) could be fortned. The formation of pltotoproduct is in agreement 
with this mechanism (Scheme- 3B.3). 
Irradiation of DIF (4) under anerobic condition at pH 4.5 where it is present as the 
cationic fonn" leads to the formation of photoproduct (7). The product Ibrmation can 
be explained through the given mechanism. On irradition under acidic condition. in 
the absence of oxygen DIF (4) undergoes deflourination through an Sal' type 
mechanism as recently suggested for electron-donating substituted halobenzenes"-56. 
where the internal charge transfer character of the excited state causes incipient 
heterolytic labilization on the carbon—halogen bond. The mechanism seems 
appropriate for the present substrates, due to the presence of the electron-donating 
amino group. An aryl cation intermediate formed during this proecss, which then 
involves addition of water to the excited state to give the observed photoproduct (7). 
The mechanism outlined in scheme- 38.4 well explains the observed reaction. 
The formation of rcacti.e intermediate like tee radical, earbeeu, carbanion and cation 
in the photodecornposition pathways of DIF under anaerobic condition at different pH 
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may he involved in the observed phototoxic effect of this drug as the recent studies 
couccmii 	both the photochemistry and phototo xi city of drugs have shu,rr th,ut 
intermediate such as free radical, earbeen ", carbanion " and cation s` product on 
drug photoexcitation with UV light can trigp,cr the phototoxicity through damage to 
the DNA and other biological substrates. 
The present investigation revcalsed that difloxacin—induced photosensitization leading 
to phototoxicity takes into account drug photodegradation and the reactive 
intemtediate species generated in the photodegradation pathways following the 
phuloexcitation of ditloxacin with UV —A light under anaerobic condition may be 
capable of initiating the phototoxic effects. On the basis of obtained results, it would 
seem advisable to avoid intense exposure to artificial and natural UV light during 
therapy and in all stages of drug development process, handling and storage. 
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Introduction 
Over the lust decade there has been increasing interest in the photosensitization 
mechanism in the hinlogical systems. in relation to both deleterious and therapeutic 
aspects of this phenolmenon t . Photoscnsiti Vi ty reactions may be more specifically 
categorized as pholotoxic or photoallergic in nature. Phototoxic disorders have a high 
incidence, whereas photoallergic reactions are much less frequent in human 
population'. The primary event in any photosensitization process is the absorption of 
a photon, and the following free radical and singlet oxygen generation by 
photoexcited drug molecules may seem to be the principal intermediate species in the 
phototoxic response'. Great interest has been recently shown in photodegradation and 
in vitro phototoxicity studies of drugs belonging to the pharmacological class of 
antibacterial sulphonamide derivatives drugs'. 
The sulfonamide group is considered as a chromnphores which is present in a number 
of biologically active molecules, have been clinically used for many years and found 
to posses a large number of biological activities, including antimicrobial `-`', carbonic 
anhydrase inhibitors °. anti-cancer '°, and as an anti-inflammatory agents". Benzene 
sulphonamide is a derivative of sulphonamide family have attracted intense interest in 
recent years as they are important clinical agents, main!v are used in the treatment of 
gastro-intestinal— duodenal ulcers, neurological disorders, glaucoma. altitude Sickness 
and for some forms of tumor 1 ' and some benzene sulphonamide is also clinically 
used as a antidibetic agent has been associated in some patient with the appearance 
of phototoxtc effect such as erythema, flaring and urlicarial weal 13. Thesc compound 
have been recognized as a very good photo sensitizers in clinical test and in cell 
culture 14 . Although it is very useful but it can produced adverse photo biological 
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effect such as clinical photosensitizutiun .,Iiich occurs OR the skill of patient °. The 
piirnnty reactions responsible for initiating phototoxicity can often be descihed in 
terms of basic photochemical reaction. It is therclure to obtain extensive information 
on the photoreactivity of be zenesutphonamide derivative drugs; we used a stepwise 
experimental approach involving pliotodcgradation, and an in rinv phototoxicvty 
determination by linoleic acid peroxidation assay in the following studies. 
CAI Photochemical behavior and Pholobiological Action of Photosensitive Drug 
Tolbutamide 
JBI Photochemistry of Photudynamic biological Action of Photosensitizing Drug 
Tolazanride 
Section [A] 
Photochemical behavior and 
Photobiological Action of Photosensitive 
I43 
Drug Tolbutamide 
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IAl Photochemical behavior and Photobiologica l Action of Photosensitive Drug 
Dolbtitaniidc 
'I'olbutamidc (1). a benzene sulphonamide deli vative I 	is a first generation 
potassium channel blocker, oral hypoglycemic drug. It is structurally similar to 
aectohexamide, chlorpropamide and tolazamide. Tolhutamide (1) is twice as potent as 
the related second-generation agent glipizide. This drug may be used in the 
management of type It diabetes if diet alone is not effective. Tolbutamide (I) 
stimulates the sccrgfioa ul insulin by the panercas. Since the panorcas must synthesize 
insulin in order for this drug to work, it is not effective in the management of type 
diabetes (condition in which the body does not produce insulin, and therefore, cannot 
control the amount of sugar in the blood), It may be effective in some patients who 
have become unresponsive to one or more of the other suiphonylurea dntgs. It 
generally has a short duration of action clue to its rapid metabolism, and is therefore 
safe for use in elderly diabetics ~°. Tolbutamide (I) with sulfonamide chromospheres 
is expected to be photolabi]e and probable photo sensitizer of biological substrate and 
it is also known to exhibit phototoxic effect in patient treated with this drug ""''. In 
continuation of our previous work we became interested in itrvestigating the 
photochemical behavior of the folbutamide (I) under aerobic condition in UV- H 
light for all appropriate correlation to its photo toxicity. Photolysis of tolbutoWide (1) 
in presence of oxygen resultant in the formation of two degradation products 
ldLailed as (2) and (3) ti-on' their spectral properties: ('EI-NMR, ''C-NMR, IR and 
Mass spectra) is shown in scheme- 4A. 1. Product (2) and (3) presumably produced by 
the cleavage of CO-N bond of tolbu tamide (1). 
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Experimental 
4pparatrrs 
All chemicals used were of analytical r[nd pharmaceutical grade. Tolbularride (I) was 
extracted from commercial medicament Rastinone (Avemis Parma Limited, India) 
-The purity of drug extracted was checked by I LC and comparing its melting point 
with the literature value. Rose bengal and reduced gluthione (GSI1) were purchased 
from Sigma Aldrich (India)_ 
Chemicals 
Photochemical reactions were carried out in quartz fitted immersion well 
photochemical reactor equipped with 400W medium pressure mercury vapour lamp 
with continuous supply of water. LV spectra were recorded on a Shimadzu 160 A 
Instrument. IR spectra were recorded in KBr discs on a Perkin Elmer model spectrum 
RXI. 'H-N.M.R and ''C-N.M.R Spectra were recorded on a Broker Avance DRX - 
300 Spectrometer using SiMe4 as internal standard and CDCI3 as solvent. High 
resolution mass spectra were determined with a VG-ZAB-BEQ 9 spectrometer at 70 
eV ionization voltages. Column chromatography was performed on silica gel 60 (70- 
230mesh); thin layer chromatography (TLC) was carried on Merck silica gc16O F 251 
(0 2 mm thick plates). 
Irradiation of tolbutam ide in inrthdnre! 
Tolbutamide (1) 285 mg (].06 mM} was dissolved in 400 in] methanol and irradiated 
at room temperature in the Rayonel photochemical reactor . Progress of the reaction 
was monitored by thin layer chromatography (chloroform-methanol, 983). After the 
irradiation of mixture for 71 hr the solvent was removed in a rotary evaporator and 
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crude product Was subjected to silica ,11c1 COlunln chromatography elution With 
(II ;C'\ II () (_;U:TO. 	on :ili a eI colurttn 	1\ c 2 and 3 as hltotopruclucts. 
1)'I1tahrnIi:ii1r-1 (2): 
1'ield:00im.: (2 l. 	'', ). l \ i_,, (McO11) 21() inn . IIR.\IS caledt. ti,r (NI ) C'411 i1 \ 
73.33.tmurici 73.20, IR(KBBr): 3350, 2967.2 OI090. S0O cm YiINMR(('[)('1 o,pfitn) 
2.7 (t. J-7?11, f 1-I). 1.43 (rn.411.I I-3&1I-4), 1.16 (s,2I1. N1l,), O.92( t, _f 7 Hi. 1I. 
11-4) : 	('-NMR(('1)('l;.63hpr1i) 41.,X (C-I). 5.O (('-2), 19.9 (('-3), 1 3. (('-4). MS: 
in'z: 73 (NI ). 0(\I -Cl I— \H.) 
,\'-tos rlfnrinamide (3): 
Y iel(t: 9-5tng(34.1 	): UV i_„...\ (MeOl 1) 261 tali and 210 nm : HRMS Baled. for (M' ) 
( H9NO,S 199 2270. found 199. 268:1R(KBr): 3359, 33 5cm-1(NH), 1340, 1 160ctn' I 
(SO2): 'H-NMR (CDC1 . ppm) .75(.I H.CHO) 7.82 (d. J=7.9 Hz.2H,tctivl H-3 and 
H-5) 7.32 (d. J-7.91 ir. ?H,tolvl 11-2 and H-6).2.35 (s,3H tc,ly l.('H1). 2.O(.1 H.NH ). 
"C'- NMR (('IX'I;. S, ppm) O 175.O1 (('O.('HO). 142.6. 136.9. 129.8 128.3. 23.4, (('-
I. ('-4. ('-? and ('-6. C-3 and('-5.C113of the toluene moiety). MS: rn/z: 199(M * ) 
185(M- -CI1 ), 170(M -}ICO). 15>(M'-IICOIy1I).92(M'-H('ONHSO~). 
To observe a possible quenching effect of the tolbutamide (1) on singlet oxygen ( 1 (J') 
tglhutannide (1) was also Ia(liate(l in presence of photosensitizer rose bengal and 
maintaining all ether experimental conditions the same. 
Photo%en.%iti: c'd /,c'r n.VidatiOlt of' liii oleic acid 
PhOSIAIMe buffered solution Of I inc,leie acid (1 x l 0'' Ni) was irradiated in the presence 
Of compound (1) and also in a pre-irradiated solution Of I (I x I (-. ).The formation of 
clienic hvdrop roxicie, was monitored h t_"\'-spectrophotometer. by the appearance 
 new hand at i_ 233nm- ( ig-4A.I ). 1 he Iihicl 
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peroxidationn test 'vas rcpcaled in the picsunuc oI reduced gl tnathione (GSH ) as radical 
scavenger. This test was also carried out under argon atmosphere. 
Results and discussion 
Irradiation oI methanolic solution of (1) under oxygen atmosphere wills a medium 
pressure mercury vapor lamp in an i minersion well type photo reactor gave two 
hernolytic cleavage pholoproduets: butanantinc-1(2) and N-tosvllormtimidv (3) as 
shown in scheme-4A. 1. The assigned structures to these products well correspond to 
their observed spectral properties. 
No degradation of tolbutamide (1) was observed when irradiation was carried out in 
the presence of rose bengal maintaining all other experimental conditions the same. 
This indicated that quenching of singlet oxygen by tolbutamide (1) was negligible in 
the presence of rose Bengal, which is a well known efficient singlet oxygen generator. 
Hence, it is proposed that tolbutamide (l) undergoes hemolytic cleavage of CO-NH 
bond resulting in the generation of two intermediates radicals (2a) and (3a), as 
presented in schemc-4A 2 
Hydrogen abstraction by intermediate radicals generated in tolbutamide (1) 
photodegradation leads to lipid peroxidation (Scheme-4A.3).The efficient inhibition 
of lipid peroxidation by well-established radical scavengers GSII confirmed the 
involvement of type I mechanism. 
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Lipid peroxidations celainly correlate with damage produced in the cell membranes. 
The phototoxicity mechanism for tolbutamide (1) most probably involves reaction of 
free radical imermediates and photoproducts with cellular eoutponenh_ The 
insignificant decrease in lipid peroxidation test under argon atmosphere indicates that 
tolbutamide iss capable of photosensitizing lipids through a process where oxygen 
does not a play principal role. 
The studies of phototoxicity carried out in this work may help to explain the damage 
produced in protein and organs. The observations in this work may contribute to 
elucidate the observed accumulations and damaging activity of oxidized proteins 
during aging and in pathologies such as diabetes, atherosclerosis and 
neurodegenerative diseases. Lipid photoperoxidation certainly correlates the damage 
produced in the cell membranes. The phototoxicity mechanism for tolbutamide (1) 
most probably involves reaction of free radical species than singlet oxygen, super 
oxide anion or photoproducts with ceUulnr eotnpoucnts_ The result obtained may be 
very useful from medical point of view to perform the appropriate screening of 
phototoxicity in vitro before introducing drugs and chemicals in to chemical therapy. 
Section B 
Photochemistry of'Photodynuinic 
biological Action of Photosensitizing 
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Drug Tolazamide 
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[B1 Photochemistry of Photodonamic biological Action of Photosensitizing Drug 
Tolaiamide 
Tolazamide (4, A'-[(ozepan-l-ylamino) carbom'I]- -methylbenzenesulfonemide) is a 
member of a class of oral hypoglycemic agents2 and chemically known as 
sulfonylureas which includes other compounds such as tolbutamide, Chlorpioniarnide, 
glyburide and glipizide t4. All are aryl sulfonylur as containing substitution on the 
urea and benzene groups. They are effective in the treatment of Type II diabetes 
mellitus which usually occurs in later life 25 ioluzamide (4) is approximately live 
times more potent than tolbutarnide in the human diabetic 20. The typical individuals 
who would benefit from tolazamide therapy would be one whose type I1 diabetes 
developed after the age of forty- Tolazamide. as well as other sulfonylureas, is 
ineffective in the treatment of type I diabetes mellitus which usually occurs in 
children and young adults''. The mechanism of action of tolazamide, typical of other 
sulfoaylureas, is its ability to stimulate the secretion of insulin from functioning [1 
cells of pancreatic islet tissue 's. In addition tolazamide, as well assome other 
sulfonylurcas, has been shown to be effective in lowering, blood glucose levels of non 
insulin dependent diabetics whose disease dose not respond to diet caloric restriction 
or physical activity ". 
Tolazamide (4) with suifonamide chromophores is aspected to be photolahile and 
probable photosensiti2er of biological substrate. Interest in the photochemistry of 
tolazamide arises from the clinical and pharmacological reports of phototoxic effects 
which is associated with the use of this drug -`. In this study, our goal was to 
characterize the photochemical properties of tolazamide {4), in order to understand 
and rationalize the basic photochemical reaction involved in the phntotoxicity. 
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Photolysis of tolazamide (4) in the presence of oxygen resulted in the formation of 
Two photodegradation products. identified as (5) and (6) from their spectral QR, 'H- 
NMR, 't-NMR, mass spectra) properties (Schcmc-4B.1).Product (5) and (6) 
presumably produced by the rupture of CO-N bond of tolanamide (4). 
Experimental 
Chemicals 
All chemicals used were of analytical and pharmaceutical grade. Tolazamide (4) was 
extracted from the commercial medicament Tolinase (Pfizer, India) The purity of 
drug, extracted was checked by thin layer chromatography (TLC) and comparing its 
melting point with the literature value. Rose bengal and reduced glutathione (OSH) 
were purchased from Sigma Aldrich (tndia)- 
Apparatus 
Photochemical reactions were carried out in quartz fitted immersion well 
photochemical reactor equipped with 40OW medium pressure mercury vapour lamp 
with continuous supply of water. LIVspectra were recorded on a Shimadzu 160 A 
Instrument. IR spectra were recorded in KBr discs on a Perkin Elmer model spectrum 
RXI. 'H-NM Rand C-NM  R Spectra were recorded on a Bruker Avance DRX-300 
Spectrometer using SiMc4 as internal standard and CDCI, as solvent.High resolution 
mass spectra were determined with a VG-ZAB-BEQ9 spectrometer at 70 eV 
ionization voltage. Column chromatography was performed on silica gel 60 (70-230 
mesh); thin layer chromatography (TLC) was carried on Merck silica gel 60 F 2 4(0.2 
mm thick plates). 
Irradiation of totil'-u►►ticic' ill !►►rt/tuIlrl 
fk1azaniide (4; ' 7 ', nu` 111.' 111\19 \ a dI 01\ cii In 40O nil nnetliiiiol lncl Irraeliated at 
room temperature in the R a% ,net 1hltlehcnlh;al reactor . Progress oC the reaction was 
monitored hl 111111 layer chromatography (C7llol'hforlll-l71et11anol. 98:2). Alter the 
irradiation of illi.xture 1111 / ) Ill- 1111' sOI\ emit 'as removed in a rotary evaporator and 
crude product was subjected to silica "Cl CoILIII111 chromatography elution with 
C l 1;CN H 2O (0:70, vv )  on silica column Lai e (5) amid (6) as products. 
.-tzepu►►-1-a►»i►re (5): 
Yield: 65 milt; (23.6 %): UV i. ,,,:. (WeOI-I) 238 nm and 242 nm; FIRMS ealcd. for 
(N1') C(,H 14 N, 1 14.1888, found 114.1757: 1R (KBr): 325() (NH,), 3140, 2967.2880 
eln: I IINMR (CI)C/; 6. ppm): 2.57 (t..1 7.1 IIz. 411. 1-I-2 & 11-7), 2.0 (s, 211. NII~), 
1 .42 (ill. 4 11. 11-3  &. I 1-0. 1.28 (m. 411. 11-4 & 11-5): 1 'C-vMR (CDC'I :. 6, ppm): 61.1 
(('-2 & ('-7). 26.5 (C'-4 & ('-5), 25.5 ((.'-3 S- ('-6): NIS: mil is 114 (M'). 9$ (M*- Nil,) 
£`'-to.cvlfor►ua►►►id(' (6): 
Yield: 98 mom (35.6 %); UV i. ,, (MeOH) 261 nm and 210 nrn: HRMS calcd. for 
(M - ) CsH,,NO;S 199.2270 filund 199.2268: IR (KRr): 3359. 32.5(NI-I). 1655 
(CONH). 1140. 1160 cm-1 (SO,):'H-NV1R (1'171'1;. S. ppm): 8.75 (s. I H. ('110). 7.82 
(d. J=7.9 Hz . 2H, tolyl I1 	and 11-5). 7.32 (cl_ .1-7.o) hi. 211, tolvI 1-1-2 and 11-6), 2.38 
(s. 311. tolyl C'l=l:). 2.0 (s. 11-1. N11): °C- NMR (('DCh. 6, ppm): 175.01 (CO. ('110). 
142.6. 136.9, 129.8 128.3. 23.4. (C'-I. C-4. ('-2 and ('-6. ('-3 and ('-5. C'lI:ot' the 
toluene moiety): MS: m'i: 199 (NI'). 185 (Ni 	I'll;). I 7 (N1*- 11('(9). 155 (N1 - 
I l('C)NI1). 92 (\I - IIC'ONIlSO~). 
IS  
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To observe a possible quencher effect of the tolazamide on singlet oxygen 
tolazamide (4) was also irradiated in presence of photosensitizer rose hengal and 
maintaining all other experimental conditions the same. 
Ph oteseasirized per uridation of (iwrleic acid 
Phosphate buffered solution of Liuoleu acid (Lx LO-' M) was irradiated in the presence 
of compound (4) and also in a pre-irradiated solution of (4) (1 x 1(Y'). The formation of 
dienic hydroperoxides was monitored by UV spectrophotometry. by the appearance 
and progressive increases of a new hand at ?.=233 rim (fig-3B.1) 31. The lipid 
peroxidation test was repeated in the presence of reduced glutathione (GSH, a radical 
scavenger). This test was also carried under argon atmosphere. 
Results and discussion 
Irradiation of niethanolic solution of tolazamide (4) under oxygen atmosphere with a 
medium pressure mercury vapour lamp in an immersion well type photo reactor gave 
Azepan-1-amine (5), N-tosylformamide (6) as photoproducts (Scheme-4R. 1) which 
were characterized Irom their spectral studies_ No degradation of tolazamide was 
observed when irradiation was carried out in the presence of rose bengaL Therefore, 
the interaction with or quenching of singlet oxygen (1 02), by tolazamide was 
negligible. 
Tolazamide (4) undergoes homolytic cleavage (rupture of) CO-NIL bond resulting in 
the generation of two iuteni ediate radienEs (Sa) and (fia) (Scheme-4l3?). Hydrogen 
abstraction by intermediate radicals generated in tulazamide photodegradution leads 
to lipid peroxidation (Sehetne413.3). The efficient inhibition of lipid peroxidation by 
well-established radical scavengers (1SH continued the involvement of type I 
mechanism. 
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The hhototoXicitV mechanism for tolatainide most probably involves reaction of tree 
radical internietliatcs and 1hotoprc)cluctS v ith cellular ccrnibone:nts. I he Insi`-niIicant 
decrease in lipid peroxidatioll test under argon atmosphere indicates that tolaialnide is 
capable of photosensiliii.ng lipids through ;I pr cc' where tI\\ uen does not a pla\ 
principal role. 
the outcome Of the studies of pliototoxicity carried out in this work may help to 
explain the damage produced in cellular component. The observations in this wort: 
may contribute to elucidate the observed accumulations and (lamaging activity of 
oxidiied proteins during aging and in pathologies such as atherosclerosis, diabetes 
and neurode .!!eIneratly e diseases. Lipid phutoperoxidation certainly correlates the 
damage produced in the cell membranes. On the basis of the obtained photochemical 
results. the phototoxicritv ut- tolazamide can he attributed to radical formation. We 
hope that our results will contribute t0 a better comprehension and pre ention of the 
harnntul side reactions produced by the antidiabetic drug tolat mnide (4). 
Ilefrences 
I . \1.11. I\ Icinm,in. M. 1). Smith. L. I\Urdli. S. KIeinheter , K..Iiang. Y. 7hang. S. 
A. kentltdh'-Ci bb. A. M. Lynch. C. L). Geddes. Regal 7*().xicul PIiarimi. 2010. 
58. „4. 
'. E3. Quintero. M. A..\Iiranda. .-Irs Phartna. 20O0. 41. 17. 
3. G. Cosa, /'rn•c' . I ppl. Chem. 2004, 76. 263. 
4. F. ScIv•aa~ . P. 'I bane, Photoc/em•Inatol P/1otoimnnzimnol P/totoineel. 1996. 12. 79. 
~. Y. Genc, R.Oikanca, ' . I3ckdeinir..-lnn C'lin . /icrobio1 .'11ti,)iCmb. 2(108, 7. 
17. 
6. A. Alsughaver. A.A. Elassar, S. hlustata. F. A. Sagheer, JBNL3. 2011. 2. 144. 
7. S. Zinlnmeniian. A. Innocenti, A. Casini, J. G. Ferry, A. Scozzatav a. C. 1. 
Supuran. Rloor.   .lied ('lien: Lett. 2004. 14. 6001. 
S. L. Puccetti, G. Fasolis, D. Vu11o. Z. H. C'hohan. A. Scoz-zatava.C'. I. Saharan. 
.t1('Q ('her» Lett. 200, IS. 3096. 
9. 0. (1uzcl. A. lnnocenti, A. Scoiiafava. A. Salrnan. C.T. Supuran, Hruorg Med 
('lie,;: Left.2009). 19. 3 170. 
10. A. Scozzatava. T. Ova. A. Mastrolorenzo. C. T. Supuran. Cirri .11cd ('lien:. 
2003. 10. 925. 
1 1. A. \Veher. A. ('asini. A. Ilelne, I). Kuhn. C'. T. Supuran, A. Sc:o//atava. G. 
Kiehe. J. .1/ed. ('lien;. 2004, 47, 559, 
12. A. I hakes-..-1/?h"/[ Q(. 2005 .14. 41). 
3. E. Selva2e. . lr=neim terse/i. 1 997.47. 1(13 I 
14. ('.\V. 13ro~tn..I.S. I)en~g. .1. to.\ h el rl/n. i xtc•o/.1995, 33. 729. 
I . \l. Darken. F. \1chun1.'\..1. . I,,;..lc ad. 1e1,nelul.1 988. 18. 8. 
164 
l . I jki. 1:. I Ia__i\\'ardt. ( U. 11 iro;c. K. Sliinoiukit. K. l *n1Ct~akic . S. ' aniada, .1. 
J'Ircrr -nrcr I /1a, mural. _'O I I , 63. 12 3X. 
7. N. R. Srini as, /)l rr~..tic ttrl'. !'Ircrrn,o/ inrt. 201 1, 26. 216. 
I`. N. K. Nath.:A. Nati .t, (1-I'Jt Ln ('urrrrrr. 201 1 . 13. 47. 
1 9. R Choure. N. \'aid a . K.S. Pitre . 1)tvr ( Irc•rnicu .Sirrica. 2011. 2 . 129. 
20. I: 5cR as . 1'. I Itunc. l'hotocicrmatol I'Itotuimmunul PhOtOmLcl. 1997. 13. 4. 
. F. Selvaag, A.[3. Petersen, R. Gniaclucki, I. I ho rn. I1.C. Walt; !'Irutaclerrrrcrtul. 
1'/ru(Oirr1rra1trrul. 1'hutoinecl. 2002. 18. 90. 
22. R.O. Rec:knatul, L.A. (jlcndc:n. 195'4. In Oxyccc:n Radicals in Rioloytical 
System. k14thods in LuzyuoIog}. 105, 33 t Packer L. Eds. Academic !'ress: 
New York. 
23. P. Saha S. Datta. 1). Kumar. P. K. Halclar. ,1. C'Irc,n Sci. 201 1. 123. 335. 
24. K.\\•. Lee. Y. II. Ku. \'I. Kim. B. Y. Alin, S. S. Chung, K. S. I'ark. !)iabetes 
l f('Icrh .I. 2()1 1. 35. 340. 
25. M.1'. Kahacii, t *. NI. Kahacii . Ann P/zarnzacot/u'r.200 ), 37, 1572. 
26. A. N. Nagappa. 11c•crl!/t .1clnrinistrator. ?(112, 20. 58 
27. NI. f3octnicr. C. Aleiur. S. Krahenbultl. 1)icrhrlrs care. 2008, 31. 1( )56. 
?ti. R. 1.. Lngler. D.M. l c'11on. (il•c•rrlcrtinrr. 1996. 94. 2297. 
29. J. I. Biederman. F.vera. R. Rankhani\a. C. Ilassett. G. Giannicu. J. Yce. P. 
Fortes. hic/nc 1►rt. 2005. 67. 554. 
.0. F. Selo aa~ . ii. .\nholt. J. M. f erthunc, .1. /'hutoc Irrnr.l'hc,tuhrc,1. l?: />ic,1. 1997. 
38. N`. 
165 
31. M. A_ Miranda, Phutotoxieity of drugs, in: J.V. eri1eIl (Ed.), Alternative in 
Vitro Models to Animal Experimentation in Pharmaeotoxicologv, 
Fannaindustria, Barcelona. 1993, pp. 239-270. 
